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Abstract 
Background
Endovascular treatment (EVT) of acute ischemic stroke (AIS) requires that patients are immobi-
lized during the procedure. Retrospective studies have shown worse neurological outcome for 
patients receiving general anesthesia (GA) compared with patients receiving conscious sedation 
(CS) during EVT. Some suggested explanations for worse outcome in the GA group have been 
peri-operative hypotension, hypocapnia and attenuated cerebral autoregulation. However, the 
retrospective studies experienced pronounced selection bias, with more severe stroke in the 
GA groups, which could also explain the worse outcome. 
 Regarding traumatic brain injury (TBI), studies have shown that autonomic nervous system 
(ANS) dysfunction is associated with neurological outcome. However, the most severely injured 
patients treated in an intensive care unit, were excluded in those studies.
Methods 
Paper I was a retrospective study on neurological outcome in relation to peri-operative blood 
pressure in patients managed with GA during EVT. In Paper II, a prospective study, stroke 
patients were randomized to GA or CS before EVT and neurological outcome was analyzed. 
Paper III investigated the impact of off-hour stroke admission on in-hospital lead times for EVT, 
in a cohort merged from Paper I and II. 
 Patients with severe TBI, receiving standard treatment in a neuro intensive care unit (NICU), 
were retrospectively studied with the aim to analyze ANS dysfunction in relation to late neu-
rological outcome (Paper IV).
Results 
Profound blood pressure fall (MAP fall > 40% from baseline) during EVT was an independent 
predictor of poor (modified Rankin Scale (mRS) > 2) neurological outcome. Patients randomized 
to GA or CS had equal mRS at 3 months (primary end-point). Furthermore, there were no 
differences in short-term neurological outcome (National Institutes of Health Stroke Scale 
(NIHSS) 24 h), infarction volume, recanalization grade or complications between the groups. 
Patients admitted during off-hours, experienced a longer time interval from admission non-con-
trast computed tomography to recanalization. This time interval was an independent predictor 
of poor neurological outcome. 
 In patients with severe TBI treated in a NICU, analyzes of ANS were feasible with ongoing full 
scale NICU care. ANS dysfunction was associated with worse long-term neurological outcome.
Conclusion 
The results of this thesis on EVT in AIS, does not support the theory that anesthesia technique 
per se influences neurological outcome, provided that severe hypotension is avoided. Stroke 
management must be organized so that recanalization in EVT can be achieved as fast as possible 
around-the-clock. ANS analyzes might be adjunct tools in multi-monitoring of TBI patients in 
the NICU.
Keywords: acute ischemic stroke, endovascular treatment, general anesthesia, conscious seda-
tion, traumatic brain injury, autonomic nervous system, heart rate variability, baroreflex sensitivity
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Summary in Swedish
Populärvetenskaplig 
sammanfattning
Var tjugonde minut insjuknar någon i stroke i Sverige (20–25 000 personer per år). 
Stroke är den vanligaste orsaken till invaliditet och den tredje vanligaste orsaken till 
dödsfall i vårt land. Majoriteten av alla stroke är s.k. ischemiska stroke, vilket betyder 
att orsaken är en propp, som stoppar blodflödet i ett av hjärnans kärl. Vanliga symtom 
på stroke är hängande mungipa, sluddrigt tal, oförmåga att hitta ord och svaghet samt 
känselstörning i armen. 
Länge fanns det ingen akutbehandling för stroke, men 2002 godkändes ett propplö-
sande läkemedel. 2015 kom stora studier som visade att en annan metod, propput-
dragning, i kombination med läkemedlet, gav bättre resultat efter stroke än behandling 
med enbart propplösande läkemedel. Ett bra resultat anses vara om man kan återgå till 
ett självständigt liv efter sin stroke. På flera sjukhus, bl.a. på Sahlgrenska Universitets 
Sjukhuset, har propputdragning funnits i behandlingsarsenalen sedan 1990-talet.
Vid propputdragning förs en mikrokateter in via ljumskkärlet, upp till hjärnans kärl 
och proppen dras ut. Under ingreppet är det viktigt att patienten ligger helt stilla och 
därför behövs någon form av nedsövning. Det finns två huvudsakliga sätt att söva en 
patient inför propputdragning; fullnarkos eller lugnande medicinering. I många år, 
fr.a. efter 2010, har det varit en debatt om vilken av dessa metoder som är att föredra. 
Flera studier har visat sämre resultat för de patienter som fått fullnarkos. Dock var 
patienterna i de nämnda studierna inte lottade till sina respektive sövningssätt och 
de sjukaste patienterna (allvarligare stroke, mer samsjuklighet) återfanns i grupperna 
som fått fullnarkos. Detta faktum skulle kunna vara en förklaring till varför det gick 
sämre för dom.
Avhandlingsarbetet handlar till största delen om hur patienter, som genomgår propp-
utdragning, ska handläggas av narkospersonalen för att det neurologiska resultatet 
ska bli så bra som möjligt.
I delarbete I studerade vi en grupp patienter som alla hade fått fullnarkos. Vi visade 
att stora blodtrycksfall, som är vanligt förekommande när man sövs, kan vara en för-
klaring till att det går sämre för patienter som genomgår propputdragning i fullnarkos. 
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I delarbete II, AnStroke studien, lottade vi patienter som skulle genomgå propput-
dragning, till fullnarkos eller lugnande medicinering. I båda grupperna var vi noga 
med att undvika stora blodtrycksfall. De neurologiska resultaten visade att det var 
lika stor andel i båda grupperna som återgick till ett självständigt liv.
I delarbete III undersökte vi effekterna av att söka vård för stroke på jourtid jämfört 
med att söka på kontorstid (mån-fre, kl. 8–16). Vi fann att tiden från att röntgenunder-
sökningen av hjärnan görs tills att proppen är utdragen, förlängs med ca 20 minuter 
under jourtid, sannolikt p.g.a. lägre numerär och lägre kompetens i flera personal-
grupper. Fördröjningen har potential att påverka det neurologiska resultatet negativt. 
Delarbete IV handlar om det icke viljestyrda, s.k. autonoma nervsystemet, hos pa-
tienter som vårdas för svår skallskada på en neurologisk intensivvårdsavdelning. 
Studieresultaten visade att störningar i det autonoma nervsystemet under vårdtiden 
var kopplat till det neurologiska resultatet efter ett år.
Sammanfattningsvis har delarbeten I– III visat att det sannolikt inte är sövningsme-
toden i sig som är avgörande för det neurologiska resultatet efter propputdragning 
vid stroke, utan det totala omhändertagandet av patienten. Att undvika blodtrycksfall 
under ingreppet är mycket viktigt. Narkospersonal är involverade i ledtiderna från 
första röntgen undersökningen efter inkomst till avslutad propputdragning och det är 
av stor vikt att omhändertagandet är lika effektivt dygnet runt. 
Hos patienter med svåra skallskador är signaler från det autonoma nervsystemet 
möjliga att mäta med pågående full intensivvård och de är associerade till det neu-
rologiska resultatet.
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Introduction
Stroke
In Sweden, stroke is the main reason for neurological disability and the third most 
common cause of death after myocardial infarction and cancer. Every year, 20–
25 000 people are diagnosed with stroke. This corresponds to one person having a 
stroke almost every twenty minutes. Mean age for the stroke patient is 74 years with 
a higher incidence in men than in women (Riksstroke, The Swedish Stroke Register 
2015).
Approximately 85% of all strokes are ischemic, thus caused by a vessel occlusion 
and only 15% are hemorrhagic, i.e. intracerebral hemorrhage (ICH) and subarachnoid 
hemorrhage (SAH). For ischemic stroke, the main risk factors are atrial fibrillation, 
hypertension, hypercholesterolemia and diabetes mellitus.1 The cerebral vessel occlu-
sion is caused by an embolus from the heart or carotid vessels in 55% of the cases and 
blood clot formation in small brain vessels accounts for another 20%. In the remaining 
25% of the cases, the cause is unknown or uncommon, such as trauma, dissection 
and arteritis. The anterior cerebral circulation, i.e. internal carotid artery (ICA), the 
middle cerebral artery (MCA) and anterior cerebral artery (ACA), is involved in 85% 
of the patients.2 Posterior stroke, e.g. occlusion in the vertebral or basilar artery, has 
worse prognosis compared to anterior stroke and the two entities should be studied 
separately.3
This thesis addresses only management and treatment of acute ischemic stroke (AIS) 
in the anterior circulation.
Treatment of acute ischemic stroke
There are three milestones in modern stroke treatment. The first milestone was the 
establishment of specialist multi-disciplinary stroke units in the 1980s and 1990s. 
Medical care in a stroke unit gave an odds ratio (OR) of 1.28 for good neurological 
outcome compared to post-stroke care in a general ward.4 The approval of recombi-
nant tissue Plasminogen Activator (rtPA) for intravenous thrombolysis (IVT), in 1996 
(USA) and 2002 (Europe), was the second milestone. IVT increased the incidence of 
a good neurological outcome (ADL (activities of daily living) independence) by 10 
percentage units, compared to placebo treatment.5 Patients with AIS are eligible for 
IVT within 4.5 hours from symptom onset if a non-contrast computed tomography 
(NCCT) excludes ICH and a large demarcated cerebral infarction. Furthermore, the 
patient must have no contraindications for rtPA treatment. 
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In Sweden in 2015, 13% of all AIS patients received IVT and 91% were treated in 
a specialist stroke unit after their stroke. The seemingly low figure for IVT of 13% 
reflects the fact that patients often arrive to hospital outside the time window. Only 
37% of the AIS patients arrive within 4.5 hours from stroke onset and moreover, 
almost every fourth patient has a contraindication for IVT. 
The third milestone for stroke treatment was reached during 2015, when endovascu-
lar treatment (EVT) in combination with IVT, was proven superior to IVT as single 
treatment, above all for patients with large vessel occlusions (occlusion in the internal 
carotid artery, the first two segments of the medial carotid artery or the first segment 
of the anterior carotid artery). The combination of EVT and IVT almost doubled the 
chance of a good neurological outcome, compared to therapy with IVT only.6 EVT 
was performed in 390 patients (approximately 2% of all AIS) in Sweden in 2015 
(Riksstroke, The Swedish Stroke Register 2015).
Thus, AIS has, over a fairly short period of time, evolved into an emergency condition 
with significant therapeutic potential and outcome figures in Sweden now show a 
3-month mortality of 13% and a 3-month ADL independency of 84%. However, for 
the group of patients with large vessel occlusions, the prognosis is worse, and ADL 
independency is achieved only in approximately 40% of the cases after treatment 
with IVT in combination with EVT.7
Endovascular treatment (EVT)
Patients are eligible for EVT if the stroke severity score National Institutes of Health 
Stroke Scale (NIHSS) is ≥ 6, an occlusion is visible on a computed tomography angio-
graphy (CTA) and a NCCT excludes ICH and a large demarcated cerebral infarction. 
Computed tomography perfusion (CTP) is used in many centres to differentiate be-
tween manifest cerebral infarction versus penumbra (“tissue at risk”). 
Vascular approach for EVT is mainly via the femoral artery, but puncture of the 
common carotid artery is sometimes required due to arteriosclerosis and vessel tor-
tuosity. A micro-catheter is advanced, under fluoroscopy and angiographic imaging 
guidance, into the intracranial vessel of interest. In the beginning of the EVT era, 
arterial rtPA was infused for local thrombolysis and the first industrial specialised 
embolectomy device (Merci® retriever) was approved in 2003. However, in our in-
stitution, successful endovascular embolectomies have been performed since 1994, 
initially by Gunnar Wikholm.8 
EVT devices can be divided into two main groups: those with a proximal approach 
and those with a distal approach. In a proximal approach, the device never deliberately 
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passes the embolus during the procedure (Penumbra aspiration system®, Goose-
Neck® snare). For a distal approach, there are so called stent retrievers (Solitaire®, 
Trevo®). The stent retriever passes the embolus and the stent then expands into the 
embolus and extracts it when withdrawn (Figure 1 and Figure 2). A potential problem 
with stent retrievers is that passing the embolus might cause fragmentation of it and 
thereby peripheral micro embolization.
The main target group of patients for EVT are those with large vessel occlusions, 
since these occlusions seldom are resolved by intravenous thrombolysis solely. It is 
estimated that about 6 –10% of all AIS are caused by large vessels occlusions that 
could benefit for EVT.
Figure 1. A stent retriever, with the stent expanded into an embolus. Figure reprinted with 
permission from the publisher (CIRCE; Cardiovascular and Interventional Radiological Society 
of Europe).
Figure 2. Embolus withdrawn from a cerebral vessel.
Stent
Blood vessel
(caught in stent and removed)
Blood vessel (arteries)
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Time is brain  
The time interval from stroke onset to revascularization of the occluded vessel is 
of paramount prognostic importance both in IVT and EVT. “Time is brain” is a 
phrase used to emphasize that for every minute without revascularization, 1.9 mil-
lion neurons, 14 billion synapses, and 12 km of myelinated fibers are destroyed and 
consequently the treatments should be instituted as soon as possible in every single 
case.5, 9, 10 The goal for “door-to-needle” time in IVT is < 40 min in Sweden and the 
time window for secure IVT is 4.5 hours from stroke onset. After 4.5 h, the risk of 
intracerebral hemorrhage might outweigh the benefit of treatment (Riksstroke, The 
Swedish Stroke Register 2015). 
For EVT, national and international benchmark lead times are missing. The region 
of Västra Götaland guidelines propose a CT to groin puncture time of < 60 minutes. 
The time window for EVT is now established to be 6 hours from stroke onset, based 
on several randomized trials, but it can be expanded to > 6 hours when image-based 
selection criteria are used to identify patients with salvageable brain tissue.6 
On-hour versus off-hour
Continuous work is done in hospitals to minimize all lead times in the stroke chain, 
both pre-hospital and in-hospital. The “weekend effect” refers to the assumption that 
stroke admissions off-hour (on-call time) have longer in-hospital lead times com-
pared to on-hour (office hours) admissions. This phenomenon is described in several 
studies for IVT11-16, but for EVT it is not well studied.17-19 Obviously, EVT is a more 
complex procedure than IVT and during off-hours, hospital staffing is inevitably 
reduced. This might alter an otherwise well-organized work flow achieved on-hour 
in the neurology-, radiology- and anesthesiology departments, which are all involved 
in in-hospital stroke care. 
Anesthesia during endovascular treatment
During EVT it is necessary that the patient is immobile and usually some type of 
anesthesia/sedation is required. In parallel to the studies proving the efficacy of EVT 
in the 2010s, there has been a debate on whether the type of anesthesia administered 
to these patients affects the neurological outcome.20-37 The two alternatives compared 
are general anesthesia (GA) with intubation and conscious sedation (CS) with sponta-
neous breathing. Both alternatives have their potential advantages and disadvantages 
(Table 1).
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Not less than sixteen retrospective studies have been published, comparing GA with 
CS for EVT 38-55, together with review articles 56-63, guidelines 64-66 and one meta-analy-
sis67. All retrospective studies show that GA patients have worse neurological outcome 
compared to CS patients. The reasons for this are suggested to be intra-operative 
hypotension and/or hypocapnia in the GA group. Furthermore, GA is described as 
a more time-consuming procedure and the GA patients could suffer from ventila-
tor-associated complications due to delayed extubation. However, all retrospective 
studies experience pronounced selection bias, with the GA groups having more severe 
strokes and in some studies a higher proportion of posterior strokes, compared to the 
CS groups. 
• Airway protection during the  
intervention
• Less time consuming due to  
total immobilization
• Less risk for intra-procedural 
complications due to total  
immobilization
• Control of ventilation (PaCO
2
) 
and oxygenation (PaO
2
)
• Neuroprotective effects  
of drugs?
• Less risk of hypotension during 
the intervention
• Possible to perform repeated 
neurological assessments during 
the intervention
• Earlier mobilization
• Hypotension during anesthesia 
induction and during the  
intervention
• Time delay due to intubation
• Risk of aspiration during the 
anesthesia induction
• Attenuation of cerebral auto- 
regulation by anesthetic drugs
• Need for longer postoperative 
recovery 
• Risk of delayed extubation and 
pneumonia
• Stress and shivering during  
anesthesia recovery – risk of 
cardiac arrhythmias/ischemia
• Risk of aspiration during  
the intervention
• Time delays due to patient 
movements
• Risk of intra-procedural  
complications due to patient 
movements
• Hyperventilation leading to 
hypocapnia
• Hypoventilation leading to 
hypoxia
• Patient discomfort, stress –  
risk of cardiac arrhythmias/ 
ischemia
Potential advantages
General anesthesia
Conscious sedation
Potential disadvantages
Table 1. Potential advantages and disadvantages of GA and CS.
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Randomized trials have been repeatedly requested. In 2013–2015, the AnStroke trial, 
the SIESTA trial68 and the GOLIATH trial69 were therefore launched with the aim of 
comparing the neurological outcome after GA and CS during EVT for AIS.
Blood pressure in acute ischemic stroke
At hospital admission, over 85% of the stroke patients have a systolic blood pressure 
(SBP) >150 mmHg, that spontaneously declines over several days. Several studies 
have shown a U-shaped relationship between the spontaneous blood pressure at ad-
mission and the neurological outcome after stroke, with the best outcome achieved 
at a SBP around 150 mmHg.70 The term U-shape means that very low and very high 
blood pressures are associated with worse outcomes. However, a causal relationship 
between the spontaneous BP and outcome has never been proven. For a patient treated 
with IVT, BP < 180/105 mmHg is recommended for 24 hours, to minimize the risk 
of symptomatic ICH.71 
Relevant in both IVT and EVT is that, during the time from stroke onset to reper-
fusion, the brain tissue distal to the occlusion is completely dependent on collateral 
circulation. The effectiveness of the collateral circulation, in turn, relies on sufficient 
cerebral perfusion pressure (mean arterial pressure minus intracerebral pressure), 
especially in the ischemic situation when the cerebral autoregulation is likely to be 
disturbed.72
Collateral circulation
The four blood vessels supplying the cerebral hemispheres (left- and right carotid ar-
tery and left- and right vertebral artery) are all connected at the skull base through the 
circle of Willis. This collateral system is complete in only 40–50% of all individuals 
and is of importance in AIS only if the occlusion is situated proximal to the circle. If 
the occlusion is more distal, effective collateral circulation depends on the leptome-
ningeal collaterals extending over the brain surface, seen in approximately 80% of 
AIS patients (Figure 3). These collaterals are dormant under normal conditions, but 
are recruited when one of the large vessels are occluded, although the exact temporal 
onset of recruitment is not yet known. Existence and extent of leptomeningeal collate- 
rals demonstrate individual variations and they are an important prognostic factor for 
infarction size and neurological outcome in AIS.73 
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Figure 3. Intracranial arterial collateral circulation in a lateral (A) and frontal (B) view. Shown 
are posterior communicating artery (a); leptomeningeal anastomoses between anterior and 
middle cerebral arteries (b) and between posterior and middle cerebral arteries (c); tectal 
plexus between posterior cerebral and superior cerebellar arteries (d); anastomoses of distal 
cerebellar arteries (e); and anterior communicating artery (f). Figure reprinted from Liebeskind 
et al Stroke. 2003;34:2279-2284 with permission from the publisher.
Cerebral autoregulation
Autoregulation is defined as the intrinsic ability of an organ to maintain a constant 
blood flow despite changes in the perfusion pressure. This is mediated by metabo- 
lic- and myogenic intrinsic mechanisms, among others. Human cerebral circulation 
shows an excellent autoregulatory capacity and when cerebral perfusion pressure 
falls or increases, arteries and arterioles dilate or constrict, respectively, keeping 
the cerebral blood flow relatively constant through a range of mean arterial pressure 
(MAP) 50–150 mmHg in healthy subjects.74
However, both illness and pharmacological substances can diminish the autoregulato-
ry capacity, e.g. hypertension, stroke and sedative drugs.72, 74 Impaired autoregulation 
leads to a more pressure-dependent blood flow. Thus, AIS patients during anesthesia 
are very dependent on an adequate perfusion pressure to maintain the collateral 
circulation until the occluded vessel is recanalized.
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Traumatic brain injury
Traumatic brain injury (TBI) is the most common cause of death and disability in 
young people, both worldwide and in Sweden. The most common causes for TBI in 
Sweden are falls, motor vehicle accidents and abuse. Seventy-five percent of the pa-
tients are male, most often < 30 years old and 25–50% are intoxicated at admission. 
In Sweden, the incidence of traumatic brain injury is about 260/100 000 inhabitants/
year. Severe TBI, defined as Glasgow Coma Scale (GCS) 3– 8 at admission, has an 
incidence of approximately 700 cases/year.75-77
This thesis addresses the autonomic dysfunction in the acute phase of severe acute 
TBI, defined by requiring neuro intensive care, although some of the patients initially 
were scored GCS > 8.
Autonomic nervous system
The autonomic nervous system (ANS) has two components: the sympathetic nervous 
system and the parasympathetic nervous system, both affecting the sinoatrial node in 
the heart. A constant and varying influence from both these nervous systems makes 
the heart rate change a little from beat to beat. This creates variability in the length 
of the R-R interval – the “heart rate variability” (HRV). 
The baroreceptor reflex is a homeostatic mechanism that helps to maintain blood pres-
sure at a nearly constant level, by modulating the sympathetic and parasympathetic 
nervous systems, which lead to changes in heart rate in response to changes in blood 
pressure. Important arterial baroreceptors are located in the carotid sinus and in the 
aortic arch. Baroreflex sensitivity (BRS) is a measure of the activity/sensitivity of the 
reflex. The baroreceptor reflex is one of many processes affecting the HRV (Figure 4).
Measurements of HRV and BRS thus give indirect measurements of the ANS ac-
tivity.78 The requirement for HRV analysis is detection of R-R intervals by a routine 
continuous ECG. For BRS also measurement of arterial blood pressure is required. 
The term autonomic dysfunction refers to lower HRV and lower BRS than normal.
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Autonomic nervous system and outcome
The link between HRV and clinical outcome was first suggested in the 1960s in fe-
tal monitoring studies, and fetal HRV monitoring (CTG, Cardiotocography) is now 
standard in maternity care. In anesthesia and intensive care, autonomic dysfunction 
has been described as an adverse prognostic sign in several different entities such as 
myocardial infarction, sepsis, multi-trauma and brain injury.79 
It has been shown in several studies that autonomic dysfunction in TBI correlates 
with increased morbidity and mortality.80-83 However, most studies did not include 
the severe TBI patients, treated in the ICU with anesthetic drugs and mechanical 
ventilation. The autonomic nervous system is affected by a numerous factors inhe- 
rent to the intracranial injury as well as by the clinical management in the ICU.84-95 
Studies of HRV and BRS in patients with severe TBI treated with standard intensive 
care, including mechanical ventilation, analgesia, sedatives and vasoactive drugs were 
lacking when Paper IV was published.
Figure 4. Sympathetic and parasympathetic regulation of the heart and the baroreceptor 
reflex. CNS; central nervous system, la; left atriu, lv; left ventricle, ra; right atrium, rv; right 
ventricle, SA; sinoatrial node, Ix; glossopharyngeal nerve, x; vagus nerve. Figure reprinted 
from McNeill et al. Neural Development 2010, 5:6 with permission from the publisher. 
baroreceptors
circulating
catecholaminesadrenal
medulla
sympathetic
trunk
baroreceptors
SA 
node
sympathetic
Ix
x
x
la
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9Introduction
Aim
The aims of this thesis were:
• To evaluate the impact of intra-procedural hypotension on neurological outcome 
for patients with acute ischemic stroke undergoing embolectomy under general 
anesthesia. (Paper I)
• To compare neurological outcome after embolectomy for acute ischemic stroke in 
patients randomized to general anesthesia or conscious sedation. (Paper II)
• To evaluate the effect of off-hour admission on in-hospital time intervals for patients 
undergoing embolectomy for acute ischemic stroke. (Paper III)
• To test the hypothesis that autonomic dysfunction in patients with acute traumatic 
brain injury, treated with standard intensive care treatment protocols, can predict 
poor late neurological outcome. (Paper IV)
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Patients and Methods
Paper I–III
Stroke alarm organization
All patients primarily admitted to our institute as acute stroke alarms are transported 
directly to the CT laboratory in the Radiology department, bypassing the emergency 
room to save time. The stroke team, consisting of a vascular neurologist, a neurology 
nurse responsible for intravenous thrombolysis and a neuroradiologist, is waiting for 
the patient in the CT room. The neurointerventionist is contacted prior to the CT scan 
if a suspicion for large vessel occlusion exists. Also the anesthesiologist receives the 
stroke alarm to be prepared if EVT is appropriate. During night shifts the stroke team 
consists of a neurologist, an anesthetist nurse responsible for intravenous thrombolysis 
and a radiologist on call. 
There is a parallel workflow and the NIHSS evaluation is done by the neurologist 
simultaneously as the patient is prepared for the non-contrast computer tomography 
(NCCT) scan and interrupted when the CT staff is ready. If needed the NIHSS evalua- 
tion is completed during evaluation of the NCCT. A computed tomography angio- 
graphy (CTA) is performed in case of a large vessel occlusion suspicion, according 
to NIHSS evaluation (NIHSS ≥ 6) and/or radiological indirect signs. As soon as a 
proximal (internal carotid artery, M1 and M2 segments of middle cerebral artery, A1 
segment of anterior cerebral artery) occlusion is detected in the CTA, a computed 
tomography perfusion (CTP) is performed and the patient is transported to the neu-
rointerventional suite. The CTP is evaluated while the patient is transported to the 
neurointervention unit. Patients admitted via a regional hospital have already under-
gone NCCT and CTA and are transported directly to the neurointerventional suite. 
Imaging for stroke
NCCT (non-contrast computed tomography) is performed to rule out stroke mim-
ics (e.g. tumors), intracerebral hemorrhage and to evaluate the infarction expansion 
(ASPECT score). 
CTA (computed tomography angiography) is a contrast enhanced examination. By 
using intravenous radiopacity, arterial or venous vessels can be visualized, depending 
on in which phase the image is taken. The CTA confirms a vessel occlusion, gives 
details on occlusion site and is also used to grade the collateral circulation.
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CTP (computed tomography perfusion) gives information on the relation between 
manifest cerebral infarction versus penumbra (“tissue at risk”). After an intravenous 
radiopacity injection, mean transit time (MTT) for blood through the brain tissues is 
calculated, as well as the cerebral blood flow (CBF) and the cerebral blood volume 
(CBV). Compared to the unaffected brain tissue, the infarction core has a prolonged 
MTT, a decreased CBF and a reduced CBV. Potentially salvageable tissue, the penum-
bra, also has a prolonged MTT and to a lesser degree decreased CBF but, importantly, 
a normal or even increased CBV (if vasodilatory autoregulation is active). 
In DSA (digital subtraction angiography), intra-arterial radiopacity is injected into 
the cerebral vessels of interest, in a catheter inserted via the femoral artery. By “sub-
tracting” all other tissues (bone, brain) visible in the pre-contrast image, the DSA 
image clearly visualizes only the contrasting intracerebral vessels. DSA confirms the 
existing vessel occlusion and the images are used when performing the embolectomy 
and also for evaluation of the result.
Time intervals
Time intervals in this thesis were calculated based on the following time points:
Stroke onset is the time for onset of symptoms or the time when the patient was last 
seen normal.
CT refers to the start (time-log on the first NCCT slice) of the NCCT examination.
Arrival to neurointervention suite is the time the patient arrives to the neurointerven-
tion suite from the CT room or from a regional hospital with ambulance transport.
Groin puncture is the time when the neurointerventionist punctures the femoral artery.
Recanalization is defined by the time for the first angiographic image where reca-
nalization is visible.
End of procedure is determined by the time for the final angiographic run in case of 
an unsuccessful recanalization.
Several important time intervals (Figure 5) were calculated from these time points.
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Devices for endovascular treatment
During the years 2007–2016, several different endovascular devices were used in 
our institution at the discretion of the attending neurointerventionist. The three main 
devices used were: The GooseNeck® snare, Penumbra aspiration system® and Soli-
taire® stent retriever (Figure 6 – 8). Sometimes, in case of distal small fragmentation 
embolus, intra-arterial rtPA was used.96
Figure 5. Time intervals in endovascular treatment for acute ischemic stroke.
Figure 6. GooseNeck® 
snare. Reprinted with  
the permission from  
Medtronic.
Figure 7. Penumbra Aspi-
ration system®. Reprinted 
with the permission from 
Penumbra, Inc.
Figure 8. Solitaire® stent 
retriever. Reprinted with  
the permission from 
Medtronic. 
CT to recanalization
CT to groin puncture
Stroke onset CT Neurointerventional 
suite
Groin 
puncture
Recanalization
Stroke onset to recanalization
Stroke onset to groin puncture
Stroke onset to CT
IVT EVT
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Baseline and outcome measurements
NIHSS
NIHSS (National Institutes of Health Stroke Scale) developed 1983, is a tool for 
quantitative measuring of stroke severity. It can be administered bedside and is used 
to determine appropriate treatment, follow treatment effects and has been shown 
to be a predictor of both short and long term outcomes of stroke patients.97 The 
neurological examination evaluates the level of consciousness, language, neglect, 
visual-field loss, ocular movements, motor strength, ataxia, dysarthria, and sensory 
loss. The scale is valid for occlusions in the anterior circulation. The range of score 
is 0– 42 points (Figure 9).
An approximate grading can be presented as:
NIHSS 0 – 1 Normal
NIHSS  1 – 4  Minor Stroke
NIHSS  5 – 15  Moderate Stroke
NIHSS  15 – 20  Moderately Severe Stroke
NIHSS  > 20  Severe Stroke 
ASPECT
ASPECT (Alberta Stroke Program Early CT) score is a 10-point score that rates the 
presence of early ischemic changes in 10 predefined regions of the MCA territory on 
a NCCT. The score can be used before eventual therapy to guide decision making 
and after therapy to evaluate outcome.98
A NCCT with ASPECT score of 10 is without signs of ischemia in the MCA territory. 
Scores ≤ 7 correlate with both poor functional outcome and symptomatic intracerebral 
hemorrhage if revascularization is achieved.
Figure 9. NIHSS (National Institutes of Health Stroke Scale). 
Image created by Å Kuntze Söderqvist. Reprinted with permission.
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1a. Level of Consciousness (LOC)
1b. LOC Questions (Month, age)
1b. LOC Commands (Open/close 
eyes, squeeze hands)
 2. Best Gaze (Eyes open – patient 
follows examiner’s finger or face)
3. Visual Fields (Introduce visual 
stimulus/threat to patients visual field 
quadrants)
4. Facial Paresis (Show teeth, raise 
eyebrows and squeeze eyes shut)
5a Motor Arm – Left
5b Motor Arm – Right (Elevate arm 
to 90° if patient is sitting, 45° if supine)
6a Motor Leg – Left
6b Motor Leg– Right  
(Elevate leg 30° with patient supine)
7. Limp ataxia (Finger-nose,  
heel down shin)
8. Sensory (Pin prick to face, arm, 
trunk and leg – compare sides)
9. Best language (Name items,  
describe a picture and read a  
sentence)
10. Dysarthria (Evaluate speech  
clarity by patient repeating listed 
words)
11. Extinction and Inattention  
(Use information from prior testing to 
identify neglect or double simultane-
ous stimuli testing)
0 = Alert; keenly responsive
1 = Arouses to minor stimulation
2 = Requires repeated stimulation to arouse
3 = Unresponsive, coma
0 = Answers both correctly  
1 = Answers one correctly
2 = Incorrect
0 = Obeys both correctly 
1 = Obeys one correctly
2 = Incorrect
0 = Normal
1 = Partial Gaze Palsy
2 = Forced deviation
0 = No visual loss
1 = Partial Hemianopia
2 = Complete Hemianopia
3 = Bilateral Hemianopia (Blind)
0 = Normal 
1 = Minor
2 = Partial
3 = Complete
0 = No drift 
1 = Drift
2 = Can’t resist gravity 
3 = No effort against gravity
4 = No movement
x = Untestable (joint fusion or amputation)
0 = No drift
1 = Drift
2 = Can’t resist gravity
3 = No effort against gravity 
4 = No movement 
x = Untestable (joint fusion or amputation)
0 = No ataxia
1 = Present in one limb
2 = Present in two limbs
0 = Normal
1 = Partial Loss
2 = Severe loss
0 = No aphasia
1 = Mild to moderate aphasia
2 = Severe aphasia
3 = Mute
0 = Normal articulation
1 = Mild to moderate alluring of words
2 = Near to unintelligible or worse
x = Intubated or other physical barrier
0 = No neglect
1 = Partial neglect
2 = Complete neglect 
Category Score/Description Score
Left
Left
Right
Right
mTICI
mTICI (modified Thrombolysis In Cerebral Ischemia/Infarction) grading system was 
developed in a consensus statement in 2013 and is a tool for classifying the degree of 
revascularization after endovascular treatment for stroke.99, 100 
The range of score is 0–3 with subgroups 2a and 2b (Figure 10). Score 2b and 3 are 
considered as successful recanalization. 
Figure 10. mTICI (modified Thrombolysis In Cerebral Ischemia/Infarction). Image created 
by Å Kuntze Söderqvist. Reprinted with permission. MCA; middle cerebral artery.
0
1
2a
2b
3
No perfusion
Antegrade reperfusion past the initial occlusion, but limited distal branch filling with 
little or slow distal reperfusion.
Antegrade reperfusion of less than half of the occluded target artery previously isch-
emic territory (e.g., in 1 major division of the MCA and its territory)
Antegrade reperfusion of more than half of the previously occluded target artery 
ischemic territory (e.g., in 2 major division of the MCA and their territories)
Complete antegrade reperfusion of the previously occluded target artery ischemic 
territory, with absence of visualized occlusion in all distal branches.
Score Definitions
Modified Treatment in Cerebral Ischemia/Infarction (mTICI)
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mRS
mRS (modified Rankin Scale) was originally introduced in 1957 and modified in the 
late 1980s. It is a commonly used outcome rating scale for stroke patients, categorizing 
the level of functional independence at three months after the stroke. The range of 
score is 0 – 6 (Figure 11).
In most studies mRS ≤ 2 is defined as good neurological outcome. A person with mRS 
≤ 2 is ADL independent. mRS ≤ 1 is sometimes referred to as excellent neurological 
outcome.101 
Figure 11. mRS (modified Rankin Scale). Image created by Å Kuntze Söderqvist.  
Reprinted with permission.  
 0
 1
 2
 3
 4
 5
 6
No Symptoms.
No significant disability. Able to carry out all usual activities, despite some symptoms.
Slight disability. Able to look after own affairs without assistance, but unable to carry 
out all previous activities.
Moderate disability. Requires some help, but able to walk unassisted.
Moderately severe disability. Unable to attend to own bodily needs without assistance 
or unable to walk unassisted.
Severe disability. Requires constant nursing care and attention, bedridden.
Dead
Score
The modified Rankin Scale (mRS)
Definitions
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Paper I and III
Patients
The studies were approved by the Gothenburg Regional Ethical Review Board, docu-
ments no 455-12 and no 013-13. Patients from the prospective hospital stroke database 
for endovascular treatments of AIS were reviewed for eligibility between 2007 and 
2012 (Paper I) (Figure 12).
Study inclusion criteria were: a) no intra-cerebral hemorrhage on the admission NCCT, 
b) NIHSS score of ≥ 14 when no CTA was performed or proven occlusion when CTA 
was performed, c) treatment initiation within 6 hours and d) anterior circulation stroke. 
Exclusion criteria were: a) patient managed by CS, b) missing outcome data and c) 
missing blood pressure recordings.
Paper III, combined the retrospective patient material from Paper I with the prospec-
tively collected patient cohort in Paper II. 
Methods
Patient- and stroke characteristics were retrieved from medical journals and from the 
hospital stroke database. Anesthesiological data were collected from anesthesia charts.
Analyzed variables were age, sex, co-morbidities, baseline NIHSS, occlusion site, 
time intervals, mTICI, blood glucose, ETCO2 and intra-procedural relative changes 
in MAP from baseline. Modified Rankin Scale (mRS) at three months was used as 
outcome variable.
Outcome data 3 months missing n=0
Anesthesia charts missing n=12
Use of conscious sedation n=34
Screened for eligibility n=154
Patients analyzed n=108
Figure 12. Consort diagram Paper I.
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In Paper III, the patients were divided and analyzed according to time for the admission 
NCCT. This time point is referred to as “admission” in the paper. We defined on-hour 
as office hours, e.g. weekdays between 8 a.m. and 16 p.m. and off-hour, as on-call time, 
e.g. weekdays between 16 p.m. and 8 a.m. and weekends.
Statistics
In Paper I, the cohort was divided and analyzed according to two outcome groups; 
good neurological outcome, defined as mRS ≤ 2 or poor neurological outcome, defined 
as mRS > 2.
In Paper III, differences in baseline and outcome data between the on-hour and the 
off-hour groups were checked by t-test or Mann-Whitney test for continuous variables 
and Fisher’s exact test for dichotomous data. In a second step, the cohort was divided 
and analyzed according to two outcome groups; good neurological outcome or poor 
neurological outcome. 
Independent predictors of poor neurological outcome were assessed by uni- and mul-
tivariate logistic regression. Predictors with a p-value < 0.1 in the univariate analysis 
were finally included in the multivariate regression analysis (Paper I and III). Statistical 
significance was set to p < 0.05.
Paper II
Patients
The study was approved by the Gothenburg Regional Ethical Review Board, document 
no 013-13 and registered on https://clinicaltrials.gov Unique identifier: NCT01872884. 
All patients with acute ischemic stroke admitted to our institution from November 
2013 to July 2016 were reviewed for eligibility. Inclusion criteria were: a) ≥ 18 years 
of age, b) proven occlusion in anterior cerebral circulation by CT-angiography (CTA) 
and/or NIHSS score ≥ 10 (if right sided occlusion) or ≥ 14 (if left sided occlusion), c) 
treatment initiated within 8 hours after onset of symptoms. 
Exclusion criteria were: a) the patient was not eligible for randomization due to anesthe-
siological concerns (airway, agitation etc.) at the discretion of the attending anesthetist 
b) occlusion of posterior cerebral circulation c) intracerebral hemorrhage d) neurologi-
cal recovery and/or recanalization before or during angiography e) premorbidity mRS 
≥ 4 or other comorbidity contraindicating embolectomy (Figure 13). 
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Patients with acute ischemic 
stroke assessed for EVT and 
eligibility for the AnStroke 
study (n=321)
 Randomized (n=106)
 Allocated to CS (n=52)Allocated to GA (n=54)
Received allocated 
intervention (n=46)
Received allocated  
intervention (n=45)
Converted to GA (n=7)
Puncture of common  
carotid artery n=4
Loss of airway n=1
Patient movements n=2
 Analyzed (n= 45)  Analyzed (n= 45) 
 Lost to follow-up (n=0) Lost to follow-up (n=0)
Consent withdrawal (n=1)
Excluded (n=170)
Medical reasons for GA n=38
Medical reasons for CS n=21
Posterior stroke n=29
Spontaneous recanalization n=17
Informed consent not timely  
obtained n=34
Consent denied n=5
Inclusion failure n=11
Other reasons n=15
Not meeting inclusion  
criteria (n=45)
NIHSS <10 n=13 
Stroke onset uncertain/unknown  
or ≥ 8 h n=32
Procedure interrupted (n=8) 
Inability to proceed with  
embolectomy (anatomical/technical 
problems, other vascular diseases) 
n=4
Large infarction n=1  
Spontaneous recanalization at 
angiography n=3
Procedure interrupted (n=7) 
Inability to proceed with  
embolectomy (anatomical/technical 
problems, other vascular diseases) 
n=5   
Large infarction n=1  
Spontaneous recanalization at 
angiography n=1
Figure 13. Consort diagram Paper II. EVT; endovascular treatment, NIHSS; National Institutes 
of Health Stroke Scale, GA; general anesthesia, CS; conscious sedation.
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Methods
After informed consent, patients were randomly allocated in blocks to either general 
anesthesia or conscious sedation in a 1:1 ratio using sealed non-transparent envelopes.
Anesthesiologists were involved in all procedures. General anesthesia was induced 
by propofol and remifentanil, maintained with sevoflurane and remifentanil and with 
ventilator settings aiming for normoventilation. Conscious sedation was maintained 
with remifentanil infusion. 
Systolic-, diastolic- and mean arterial pressure (MAP) were recorded every 5 minutes 
in all patients from before the start of induction of anesthesia until extubation in the 
neurointerventional suite. Blood pressure was measured by a radial arterial catheter, 
inserted as soon as possible during the procedure in all patients. Before obtaining 
intra-arterial measurements, arterial blood pressure was measured non-invasively. The 
last recorded MAP before induction of anesthesia, was defined as the baseline MAP. 
Intra-procedural MAP was expressed as fractions of baseline MAP. The occurrence of 
a > 20% and > 40% fall in MAP from baseline was noted and total time spent under 
these limits was calculated. Dopamine, ephedrine, phenylephrine or norepinephrine 
was used for inotropic and/or vasoactive treatment at the discretion of the attending 
anesthesiologist. The treatment goal was a systolic blood pressure of 140–180 mmHg 
in all patients before recanalization. 
The main embolectomy techniques were: Solitaire® stent retriever, Penumbra as-
piration system®, The GooseNeck® snare and combinations of these techniques. 
The choice of technique was at the discretion of the neurointerventionist in charge. 
Substantial patient movements, quality of angiography and vessel tortuosity were 
registered, as well as neurointerventional and anesthesiological complications. 
Age, sex, co-morbidities, administration of IVT, occlusion site, ASPECT score, col-
lateral circulation, blood glucose, partial pressure of carbon dioxide (PaCO2) and 
oxygen (PaO2) and relevant time intervals were recorded. Neurological impairment 
was assessed as NIHSS, by a neurologist at admission as well as after 24 hours, at 
day 3 and at discharge or day 4–7.
The angiographic result of the endovascular treatment was defined according to the 
modified Thrombolysis In Cerebral Ischemia/Infarction (mTICI) score. A NCCT 
scan for detection of postoperative hemorrhage was done at day 1 after treatment. A 
magnetic resonance imaging (MRI) was performed at day 3 for infarction volume 
calculation. The review of the neuroradiologic and angiographic data was done by 
neuroradiologists, blinded to neurological outcome.
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A vascular neurologist, blinded to treatment allocation and mTICI score, assessed mRS 
three months after stroke (primary end-point). Also at 3 months, an MRI was done to 
detect any new cerebral infarcts in the postoperative period that could affect the mRS. 
Statistics
The intention-to-treat principle was used for the primary analysis. 
Differences in outcome data between the GA and CS group were checked by t-test or 
Mann-Whitney test for continuous variables and Fisher’s exact test for dichotomous 
data. The mRS scores three months after the stroke, were compared using a 2 x 7 
Chi-square test. Statistical significance was set to p < 0.05.
Paper IV
Baseline and outcome measurements
GCS
GCS (Glasgow Coma Scale) described in 1974, is a scale for level of consciousness of 
patients with an acute brain injury, evaluating eye opening, verbal response and motor 
response. It is used for guiding initial decision making and to monitor neurological 
status evolution. Range of score is 3–15 (Figure 14). Unconsciousness is defined as 
GCS ≤ 8.102
Figure 14. GCS (Glasgow Coma Scale). Image created by Å Kuntze Söderqvist. Reprinted 
with permission.
Best eye response (E)
Best verbal response (V)
Best motor response (M)
1 = None   
2 = To pressure
3 = To speech
4 = Spontaneous
1 = None 
2 = Sounds
3 = Words
4 = Confused 
5 = Oriented 
1 = None 
2 = Extension
3 = Abnormal flexion
4 = Normal flexion (withdrawal) 
5 = Localising         
6 = Obeying commands
Category Score/Description Score
22 Pia Löwhagen Hendén
APACHE II
APACHE II (Acute Physiology and Chronic Health Evaluation II) from 1985, is one 
of many prognostic severity scores for ICU patients, predicting ICU- and hospital 
mortality based on a number of laboratory values and patient signs. The range of 
score is 0–71 and an increased score correlates to a subsequent risk of mortality.103 
GOSE
GOSE (Glasgow Outcome Scale Extended) from 1981 is an outcome rating scale for 
traumatic brain injury patients categorizing the level of functional independence in 
the range of 1– 8.104
In most studies GOSE ≥ 5 is defined as good neurological outcome. A person with 
GOSE ≥ 5 is ADL independent.
Patients
The study was approved by the Gothenburg Regional Ethical Review Board, document 
no 292-08. Nineteen consecutive patients with isolated TBI, requiring mechanical 
ventilation, sedation and analgesia, and with arterial- and intracranial pressure moni- 
toring for at least one week, were included 2007–2010.
The exclusion criteria were: a) multiple trauma, b) autonomic dysfunction (e.g. diabetes, 
ischemic heart disease, hypertension), c) patients with arrhythmias precluding analysis 
of HRV and BRS, d) patients treated with angiotensin converting enzyme inhibitors or 
ß-adrenergic blockers, e) registration of invasive blood pressure, intracranial pressure 
and 3-lead ECG for less than seven consecutive days and f) mechanical ventilation 
for less than seven days (Figure 15). 
Figure 15. Consort diagram Paper IV. Figure reprinted from Löwhagen Hendén et al,  
J Neurosurg Anesthesiol 2014;26:50–59 with permission from the publisher.
Subjected to signal sampling (n=33)
Excluded due to arrythmia (n=2),  
signal sampling or mechanical ventilation less 
than seven consecutive days (n=12)
Excluded due to multiple trauma (n=19), 
diabetes (n=2), ischaemic heart disease (n=3), 
hypertension (n=2)
Screened for eligibility (n=59)
Analyzed (n=19)
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Panel A 
R-R interval R-R tachogram
A software program is used to analyze the R-R intervals from the ECG. The R-R intervals 
can be plotted along a timeline in a so called tachogram with time (seconds) on the x-axis 
and R-R intervals (milliseconds) on the y-axis. The “waveform” of this R-R tachogram is then 
subjected to a so called Fourier’s transformation.
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Methods
Acquisition of data for HRV and BRS calculations were commenced in NICU and 
timing was standardized to a period of 60 minutes in the early morning (5–7 a.m.) 
free of nursing interventions. Data on clinical management (sedation, inotropes, va-
sopressors, ventilatory support, and surgical procedures) as well as the GOSE score 
one year later, were obtained from clinical records.
Heart rate variability (HRV)  
HRV is analyzed mainly in time domain and in frequency domain. Time-domain 
analyzes give a measure of the total ANS activity and frequency domain analyzes give 
a measure on the relative contribution of sympathetic- and parasympathetic nervous 
system respectively. In Paper IV, only frequency domain analyzes were used. All mea-
surements of HRV followed the “Standards for heart rate variability measurements”.78
Figure 16 explains the (computerized) process/pathway from R-R intervals in the 
ECG to HRV variables in the frequency domain.
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Panel B 
A Fourier’s transformation 
The figure shows three cosine curves on 
the top, with different frequency but the 
same amplitude. If they are merged, one 
more complex curve form (at the bottom) 
is created. A Fourier’s transformation runs 
this process in reverse, i.e it separates one 
complex curve form into the single co-
sine curves it consists of. Obviously, many 
more than three different cosine curves are 
needed to built up the real R-R tachogram 
“waveform” in panel A.
Panel C
Frequency Amplitude
The separated cosine curves, are plotted according to their different frequencies and ampli-
tude. In heart rate variability (HRV) analyzes, a 5 minutes sampling time is used as standard. 
The sum of the amplitudes, at one frequency during this period, is termed the power of that 
frequency (ms2).
Frequency, Hz
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Figure 16 A-E. The pathway from R-R intervals in the ECG to HRV variables in the frequency 
domain. Images by the author of this thesis.
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Panel D
Frequency domain
In humans, the different frequencies prove to be clustered in defined domains; the low 
frequency (LF) domain (0.04–0.15 Hz) and the high frequency (HF) domain (0.15–0.4 Hz). 
The sum of amplitudes for all the frequencies in each domain during the 5 minutes sample 
period, is termed the power of that frequency domain, representing the AUC (area under 
the curve) in the figure.
Panel E
High frequency (HF) Low frequency (LF)
In animal- and human research, it has been shown that when manipulating the parasympathetic 
nervous system by e.g. vagotomy, atropine use or deep breathing, the amplitudes in the high 
frequency (HF) domain diminish. When manipulating the sympathetic nervous system by e.g. 
stress test and stellatum blockage, the amplitudes in low frequency (LF) domain diminish and 
also, to a lesser extent, the high frequency amplitudes. The conclusion has therefore been 
that the HF component is primarily associated with parasympathetic activity, whereas the 
LF component is the result of mixed sympathetic and parasympathetic control.54 The LF/HF 
ratio gives a measure of sympathetic/ parasympathetic balance with a a high value reflecting a 
preponderance of sympathetic activity and inversely a low value reflecting a preponderance of 
parasympathetic activity. The total power of all frequency domains is termed total power (TP).
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HRV in the high (HF) and low frequency (LF) domains, as well as, LF/HF ratio and 
total power (TP), were investigated in Paper IV. Several sequential software programs 
were used for the HRV and BRS analyzes: Datex Collect ver.5 (Helsinki, Finland), 
TestPoint™ ver.7 (Measurement Computing Corporation, Norton, MA, USA), MatLab 
ver.8.1, Baro Reflex Analysis (BRA) Software ver.5.9 and BioSpect ver.1.8.
Baroreflex sensitivity (BRS) 
With an intact baroreceptor reflex, an increase in blood pressure results in a decreased 
heart rate, i.e. a longer R-R interval in the ECG. A decrease in blood pressure conse-
quently results in a shorter R-R interval. The baroreceptor reflex is activated in frac-
tions of a second, mainly by the activation/deactivation of the parasympathetic nervous 
system. The slope for change in the R-R interval per mmHg change in blood pressure 
(ms/mmHg) is taken as an index of the baroreflex sensitivity (BRS) (Figure 17).105
Figure 17. Schematic of the sequence technique for the estimation of the baroreflex sensi-
tivity (BRS). ECG; electrocardiogram. Reprinted from Persson et al, Journal of Hypertension. 
2010;19(10):1699-1705 with permission from the publisher.
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Statistics
The patients were divided in two outcome groups according to late (1 year) neurolog-
ical outcome using the GOSE score. GOSE ≥ 5 was defined as favorable and GOSE 
< 5 as unfavorable outcome. Differences in demographic data between the two groups 
were compared, by t-test or Mann-Whitney test for continuous variables and Fisher’s 
exact test for dichotomous data.
A two-way ANOVA for repeated measurements were used to assess differences in 
physiological and autonomic variables between the two outcome groups. 
The predictive performance of HRV and BRS (day 7) vs. GOSE < 5 was analyzed by 
receiver operating characteristics to calculate the Area Under Curve (AUC). 
Statistical significance was set to p < 0.05.
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Results
Paper I
We investigated the impact of intra-procedural hypotension on neurological outcome 
in 108 AIS patients undergoing EVT in GA. Median age of the cohort was 70 (62–77) 
years. Median NIHSS was 21 (18–24) and successful recanalization was achieved in 
77% of the cases with a median time from stroke to recanalization/end of procedure of 
278 (227–345) min. Favorable outcome with mRS ≤ 2 was seen in 41 patients (38%). 
In the good outcome group (mRS ≤ 2), admission NIHSS was lower, successful 
recanalization was more common, time from stroke onset to recanalization/end of 
procedure was shorter and importantly, blood pressures were higher compared to the 
poor outcome group.
Over 3200 blood pressure recordings were reviewed. Almost all patients experienced 
a substantial fall in arterial blood pressure during the general anesthesia. There was 
a trend for lower fractions of baseline MAP in the poor outcome group (p=0.069) 
(Figure 18). 
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Figure 18. Changes in mean arterial pressure (MAP), expressed as a fraction of baseline MAP. 
In patients with poor neurological outcome (mRS > 2), a more pronounced fall in MAP was 
seen after induction of anesthesia. Mean±SEM.
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The incidence of a fall in MAP > 40% from baseline was higher in the poor out-
come group (p = 0.040) and patients with a fall in MAP > 40% from baseline had a 
worse neurological outcome and no patient recovered without a neurological deficit 
(Figure 19).
The independent predictors of poor neurological outcome are shown in Table 2. The 
odds ratio (OR) of poor neurological outcome, for a patient experiencing a fall in MAP 
of > 40% from baseline during the EVT, was 2.8.  
Figure 19. Neurological outcome expressed as modified Ranking Scale (mRS) at 3 months in 
patients with and without a fall in MAP > 40% from baseline during general anesthesia. The 
proportion of patients with poor neurological outcome (mRS > 2) was higher in patients 
experiencing a fall in MAP > 40% from baseline. Figure reprinted from Löwhagen Hendén et 
al, Stroke 2015;46(9):2678-80 with permission from the publisher.
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Table 2. Independent predictors of poor neurological outcome (mRS > 2) with their adjusted 
OR and 95% CI. mRS; modified Rankin Score, NIHSS; National Institutes of Health Stroke 
Scale, MCA; middle cerebral artery, ICA; internal carotid artery, CT; computer scan tomog-
raphy, mTICI; modified Thrombolysis In Cerebral Ischemia/Infarction, MAP; mean arterial 
pressure, ETCO
2
; end-tidal partial pressure of carbon dioxide
Age, years
Sex
NIHSS
Hypertension
Atrial fibrillation
Ischemic heart disease
Diabetes mellitus
Smoker
Hyperlipidemia
Obesity
Glucose mmol/L  
First segment of MCA 
Second segment of MCA
Top of, or distal, ICA
Left hemisphere
Time from stroke onset to CT
Time from stroke onset to groin 
puncture
Time from stroke onset to  
recanalisation/end of procedure 
Lack of successful recanalization 
Interventional complications 
Ambulance MAP, mmHg   
Baseline MAP pre anaesthesia, 
mmHg
Intra-procedural
MAP, mmHg
MAP (fraction of baseline MAP)
Highest MAP, mmHg 
Lowest MAP, mmHg
Lowest MAP, fraction of  
baseline MAP
Occurrence of >20% fall in MAP 
compared to baseline
Time spent with >20% fall in 
MAP compared to baseline
Occurrence of >40% fall in MAP 
compared to baseline
Time spent with >40% fall in 
MAP compared to baseline
Use of inotropes
Use of vasopressors
ETCO
2
, kPa
1.18
1.002
25.6
2.80
0.11
0.98
0.022
0.76
0.84
0.99
0.17
0.91
0.22
0.87
0.17
0.67
0.97
0.95
0.33
0.64
0.82
0.07
0.003
0.41
0.12
0.13
0.46
0.18
0.20
0.51
0.053
0.37
0.057
0.034
0.756
0.731
0.419
0.737
0.99–1.06
0.45–2.24
1.02–1.25
0.40–1.93
0.40–2.12
0.37–2.65
0.62–14.8
0.30–3.94
0.15–1.54
0.11–14.0
0.94–1.48
0.54–2.63
0.30–3.21
0.45–2.13
0.66–3.40
0.95–1.09
0.96–1.05
1.00–1.01
2.9–172.8
0.27–23.5
0.99–1.05
1.00–1.04
0.97–1.07
0.01–2.46
0.99–1.04
0.94–1.03
0.00–1.04
0.52–5.81
1.00–1.01
1.07–5.41
0.9–1.01
0.48–2.85
0.57–3.85
0.45–1.77
1.05–1.34
0.996–1.008
2.96–250
1.09–7.19
0.008
0.513
0.003
0.032
1.02
1.01
1.13
0.88
0.92
0.99
3.03
1.08
0.48
1.23
1.18
1.19
0.98
0.98
1.50
1.02
1.01
1.01
22.3
2.54
1.02
1.02
1.02
0.15
1.02
0.99
0.05
1.74
1.01
2.41
1.00
1.16
2.94
0.89
OR
unad-
justed
OR
ad- 
justed
95% CI 95% CIp-
value
p-
value
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The main finding in Paper I was that intra-procedural hypotension was more frequent 
and pronounced in patients with poor neurological outcome. Furthermore, a fall in 
MAP > 40% from baseline was an independent predictor of poor neurological outcome.
Paper II
In the AnStroke trial, 90 patients were randomized to GA or CS during EVT for AIS. 
Median age was 72 (65–80) years, median NIHSS 18 (15–22) and median ASPECT 
score 10 (8–10). Sixty-six patients (77%) received intravenous thrombolysis before 
EVT. For the whole group, the median time from stroke onset to recanalization/end 
of procedure was 253 (213–355) minutes.
The GA and CS groups were well balanced for patient characteristics. For stroke 
characteristics, the admission NIHSS was 20 (15.5–23) in the GA group compared 
to 17 (14–20.5) in the CS group. There were no differences between the GA and CS 
group in any of the time intervals. As expected, substantial patient movements were 
more frequent and angiographic quality was lower in the CS group.
Over 2200 blood pressure recordings were reviewed. During EVT, mean MAP was 
slightly lower in the GA group, but importantly the average MAP fraction during 
the anesthesia was similar in both groups. A more frequent occurrence of a fall in 
MAP > 20% from baseline was seen in the GA group but there were no differences 
between groups with respect to the occurrence of a fall in MAP > 40% from baseline 
MAP (Figure 20). 
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Figure 20. Changes in mean arterial pressure (MAP), expressed as a fraction of baseline MAP 
in patients under GA versus CS. Mean values.  
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Successful recanalization was achieved in 81 out of 90 cases (90%) and a favorable 
neurological outcome with a mRS ≤ 2 was seen in 37 out of 90 patients (41%).
The NIHSS shifts at 24 hours, day 3 and at hospital discharge, as well as cerebral 
infarction volume day 3, ASPECTS day 3, hospital mortality and incidence of a new 
stroke at three months, were equal for both groups. There were no differences in the 
occurrence of anesthesiological or interventional complications and frequency of suc-
cessful recanalization was also similar for both groups (Table 3).
Table 3. Anesthesiological complications  
a Therapy resistant hypertension leading to premature termination of the procedure
b Delayed extubation was defined as extubation after leaving the interventional suit
c Patients converted from CS to GA
d Postoperative pneumonia was defined as the institution of antibiotic therapy due to a clini-
cal or radiological suspected bronchpulmonary infection on day 1–3 after the procedure
4 (8.9)
2
2
0
3 (6.7)c
7 (15.6)
2 (4.4)
0
1
1
3 (6.7)
6 (13.3)
0.6766
1.000
1.000
GA
Anesthesiological complications, n (%)
         Loss of airway 
         Aspiration
         Hemodynamic instability a  
Delayed extubation b, n (%)  
Postoperative pneumonia requiring treatment d, n (%)
CS p-value
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Paper III
In this study we investigated the impact of on-hour versus off-hour hospital admission 
on lead times from stroke onset to recanalization in 198 AIS patients undergoing EVT. 
Median age was 71 (64–79) years and median NIHSS was 20 (16–23). Sixty-one (31%) 
of the patients were admitted via a regional hospital and 101 (52%) of all patients 
received IVT before EVT. 
The patients were divided in two groups, the on-hour group or the off-hour group. The 
proportions of patients from regional hospitals and the proportion of patients having 
IVT did not differ between the on- and off-hour group. 
The NIHSS as well as the incidence of ischemic heart disease was higher in the on-
hour group. Time intervals were longer in the off-hour group, except the time interval 
from stroke onset to CT and the time interval from groin puncture to recanalization 
(Figure 22). 
The main finding in the AnStroke trial was that we found no difference between the two 
anesthesia techniques with respect to mRS at 3 months (primary end-point) (Figure 21). 
Figure 21. Neurological outcome expressed as modified Ranking Scale (mRS) at 3 months in 
the GA versus CS group.
General anesthesia GA
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Figure 22. Time intervals from stroke onset to recanalization after EVT for patients admitted 
on-hour versus off-hour.
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General anesthesia with tracheal intubation was performed in 153 (77%) of the pa-
tients. The proportion of patients having general anesthesia was similar in both groups. 
During the procedure the MAP fraction was lower in the off-hour group (0.79 ± 0.13 
off-hour versus 0.84 ± 0.14 on-hour, p=0.0293). The occurrence of a > 20% and > 40% 
fall of MAP from baseline did not differ between groups. 
Successful recanalization was achieved in 164 (83%) of the cases and a favorable neu-
rological outcome with a mRS ≤ 2 was seen in 78 (39%) of the patients. We found no 
statistical significant differences between the groups with respect to good neurological 
outcome (mRS ≤ 2) at 3 months or the rate of successful recanalization. 
In the uni- and multivariate analysis of predictors of poor neurological outcome (mRS 
> 2) only patients that received recanalization (mTICI 2b-3) were included (n=164). The 
time intervals included in the analysis were time from stroke onset to CT and time from 
CT to recanalization, due to co-linearity between the other time intervals. Variables 
with p < 0.1 in the univariate analysis were included in the multivariate model. The 
variables with p < 0.1 were age, NIHSS, time from CT to recanalization, occurrence 
of a fall in MAP > 40% from baseline and blood glucose. Off-hour admission, per se, 
was not associated with an increased risk of poor outcome (p=0.574).
Only two of the factors in the multivariate analysis made a unique statistically signifi-
cant contribution to the model, namely age and the time interval CT to recanalization. 
The odds ratio (OR) for poor outcome was, for age 1.045 (per year increment) and for 
the time interval CT to recanalization 1.009 (per minute increment) (Table 4).
Age, years
NIHSS
Time from CT to recanalization, 
minutes
Occurrence of MAP fall  
>40% from baseline
Glucose, mmol/L  
1.045
1.092
1.009
1.790
1.203
0.001
0.006
0.003
0.039
0.022
1.017–1.074
1.032–1.203
1.002–1.012
1.033–3.671
1.029–1.463
1.011–1.080
0.997–1.197
1.003–1.015
0.839–3.820
0.992–1.459
0.010
0.059
0.005
0.132
0.060
1.045
1.114
1.007
1.948
1.227
OR
unad-
justed
OR
ad- 
justed
95% CI 95% CIp-
value
p-
value
Table 4. Predictors and odds ratios (OR) of poor neurological outcome (mRS > 2) after 
successful recanalization (mTICI 2b-3). mRS; modified Rankin Score, mTICI; modified Throm-
bolysis In Cerebral Ischemia/Infarction, NIHSS; National Institutes of Health Stroke Scale, 
MAP; mean arterial pressure.
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Figure 23. Data on baroreflex sensitivity 
(BRS) and heart rate variability (HRV) within 
the low frequency (LF) and high frequency 
(HF) domains, as well as the LF/HF ratio and 
total power (TP), at days 3 to 7 in the neuro-
intensive care unit (NICU), in patients with 
good (GOSE > 5) and poor (GOSE < 5) late 
(1 y) neurological outcome. Mean ± SD. Fig-
ure reprinted from Löwhagen Hendén et al, 
J Neurosurg Anesthesiol 2014;26:50–59 with 
permission from the publisher.
Paper IV
In Paper IV, 19 patients with traumatic brain injuries aged 33 (± 17) years and with a 
median Glasgow coma scale (GCS) of 6 (3–13), were studied during the NICU stay. A 
GOSE score ≥ 5 (favorable neurological outcome) was seen in eleven patients (58%) and 
a GOSE score < 5 (unfavorable neurological outcome) was seen in eight patients (42%).
BRS and HRV in the LF and HF domains were significantly lower day 3–7 in patients 
with GOSE score < 5, while the LF/HF ratio did not differ significantly between 
groups (Figure 23). 
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Figure 24. Receiver-operating characteristic (ROC) curves for the abilities of baroreflex 
sensitivity (BRS) and heart rate variability (HRV) within the low-frequency (LF) and high-fre-
quency (HF) domains and total power (TP) at day 7 to predict poor late neurological outcome. 
AUC indicates area under curve. Figure reprinted from Löwhagen Hendén et al, J Neurosurg 
Anesthesiol 2014;26:50–59 with permission from the publisher.
There were no differences in age, gender, admission GCS, APACHE II score or the 
need for de-compressive craniectomy comparing patients with unfavorable outcome 
to patients with favorable outcome. No statistical differences in intracranial pressure 
(ICP), mean arterial pressure (MAP), cerebral perfusion pressure (CPP), heart rate 
(HR) or arterial partial pressure of carbon dioxide (PaCO2) were detected between the 
two outcome groups. The differential use of sedation, analgesia and vasoactive drugs 
in the two groups at day 7 are described in the manuscript.
Receiver operating characteristic (ROC) curve for the abilities of BRS and HRV (TP, 
LF domain, HF domain) at day 7 to predict poor late neurological outcome showed that 
BRS, as well as the HRV variables all had ROC areas > 0.78. Day seven was chosen 
as it exhibited the largest difference in HRV parameters between the groups in the 
two-way ANOVA analysis. A HF cut-off value of < 2.179 had the highest sensitivity 
(88%) and specificity (82%) to predict poor late neurologic outcome in this group of 
patients (Figure 24).
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The main finding in Paper IV was that consecutive daily measurements of HRV and 
BRS are feasible in TBI patients with sedation, analgesia and mechanical ventilation 
and that the measurements may identify patients with poor late (≥ 1 year) neu rological 
outcome.
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a Post-hoc analysis of data from IMS III, a randomized trial for IVT ± EVT
b Post-hoc analysis of data from MR CLEAN, a randomized trial for IVT ± EVT
c Hospital mortality 25 % (GA) vs 12 % (CS) p<0.0001
d Case fatality difference for GA vs CS 7.2% (95% CI: 2.6-12%) 
e TICI score 2-3 defined as sucessful recanalization
Table 5. The retrospective studies on anesthesia technique in EVT for AIS. The table shows 
the proportions of patients receiving GA in each study and further, stroke severity (NIHSS), 
proportions of posterior stroke, proportion of successful recanalization (mTICI 2b-3) and 
proportion of favorable neurological outcome (mRS ≤ 2) in the GA and CS groups respec-
tively. NIHSS; National Institutes of Health Stroke Scale, mTICI; modified Thrombolysis In 
Cerebral Ischemia/Infarction, mRS; modified Rankin Scale, IVT; intravenous thrombolysis, 
EVT; endovascular treatment.
Discussion
Anesthesiological aspects on acute ischemic stroke
Anesthesia technique  – retrospective studies
In all the retrospective studies, comparing GA with CS for EVT in AIS, there was 
a considerable risk of patient selection bias, since the NIHSS was higher in the GA 
group and there was an uneven distribution of posterior strokes 38-40, 43, 45, 46, 48, 49, 54 and 
co-morbidities 40, 48, 52 between the groups in several of the studies (Table 5).
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Jumaa   
Nichols   
Sugg   
Davis  
Hassan    
Langner   
Abou-Chebl    
John  
Li   
McDonald    
Whalin  
van den Berg
Abou-Chebl a
Berkhemer b 
Just   
Jagani   
Bekelis   
Author Year GA% GA GA GA GACS CS CS CSp- 
value
p- 
value
p- 
value
p- 
value
n=
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14
16
15
15
17
15
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13
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NA
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70e
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46
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51
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45
53
23
15
49
26
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46
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980
126
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124
281
190
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216
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0
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3
4
3
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2
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43
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0.1493
0.08
<0.001
0.3
0.018
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NA
19
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0.03
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<0.0001
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NA
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0.01
0.331
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0.9
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0.392
0.039
0.37
0.48
0.19
<0.0001
0.009
<0.01
0.033
<0.0001
0.0009
0.01
0.293
0.631
c
0.007
0.04
0.0006
0.024
0.182
0.02
d
2010
2010
2010
2010
2012
2012
2013
2014
2014
2014
2014
2014
2015
2015
2016
2016
2016
2017
1
40
63
13
20
4
NA
34
NA
Admission  
NIHSS Median
Posterior  
circulation %
Successful  
recanalization %
mRS ≤ 2 at  
3 months %
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Table 6. Data presented in the retrospective studies. BP; Blood pressure.
Three of these retrospective studies, found that GA was an independent predictor of 
poor neurological outcome (mRS ≤ 2), after adjusting for other known prognostic 
factors such as stroke severity (NIHSS), age and recanalization rate.45, 51, 52 In five other 
studies, the degree of recanalization was not adjusted for, which is a major limitation, 
as timely recanalization is the major determinant of neurological outcome.47, 48, 50, 54, 
55 Furthermore, adjusting for NIHSS, may not capture all aspects of stroke severity 
and pre-interventional events seen in a larger proportion in GA patients, which may 
influence outcome. 
In most of the retrospective studies several known and possibly predictive factors 
of neurological outcome are missing, such as peri-procedural blood pressure, blood 
glucose, ventilatory parameters (end-tidal carbon dioxide, arterial blood gases, pulse 
oximetry, respiratory frequency, tidal volumes) and administered anesthetic- and 
vasoactive drugs (Table 6). Thus, prospective randomized studies, with complete 
data capturing, were repeatedly requested for several years before the AnStroke trial 
(Paper II) was launched in 2013. 
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intervals
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2016
2016
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The retrospective studies present data on:
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In comparison to the retrospective studies published on EVT for AIS, the GA cohort 
in Paper I was slightly older, with similar frequencies of co-morbidities, a higher 
frequency of occluded internal carotid artery and comparable admission NIHSS 
(median 21). Our regression analyzes showed that the most important factor for good 
neurological outcome was occurrence of successful revascularization and 77% of 
our patients reached mTICI score 2b-3, which is comparable or better than in other 
retrospective studies. The neurological outcome result (38% of patients achieving 
mRS ≤ 2) was more favorable than for GA patients in all of the retrospective studies 
(Table 5).
  
Blood pressure 
The worse neurological outcome for GA patients in the retrospective studies, could 
be explained by a more pronounced peri-procedural hypotension in this group during 
the EVT. It is well-known that the vasodilatory side-effect from most anesthetic drugs 
causes hypotension, correlating to the depth of anesthesia.106
In only four of the cited retrospective studies, the role of intra-procedural hypotension 
for neurological outcome was addressed40, 42, 44, 48. Only one of the studies42 expressed 
the intra-procedural changes in blood pressure as fractions of baseline values, which 
is important, as baseline MAP varies considerably between AIS patients.70 
In two of the studies, that did present data on perioperative BP, it was shown that GA 
was an independent predictor of worse neurological outcome. To evaluate whether 
intra-procedural hypotension could be a potential contributor to poor outcome in the 
GA patients, a second regression model was constructed in both studies, substituting 
lowest SBP < 140 mmHg48 or lowest MAP < 70 mmHg42, for anesthesia type. In such 
a second regression model, low intra-procedural blood pressure was associated with 
poor neurological outcome in both studies. The problem with these analyzes was that 
type of anesthesia and blood pressure are co-linear variables, making it difficult to 
identify the role of hypotension, per se, for neurological outcome. The strength of the 
retrospective study presented in Paper I, was that the confounding of anesthesia type 
was eliminated, as all patients were subjected to GA. 
A recently published retrospective study from Whalin et el have analyzed a cohort 
were all patients were subjected to CS during EVT.107 Their results showed that pa-
tients with a 10 % MAP fall from baseline, had an OR for poor neurological outcome 
of 4.38 and for every 10 mmHg fall in MAP < 100 mmHg, the OR for poor neurolo- 
gical outcome was 1.28. These findings certainly emphasize the role of hypotension 
for poor outcome after EVT. 
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Intra-procedural hypotension, typically seen after induction of anesthesia, may impair 
important collateral perfusion to the penumbra, especially as the cerebral autoregu-
lation capacity could be diminished during ischemia and accordingly, hypotension 
could hasten the progression of manifest infarction.72 Although the data on blood 
pressure during EVT is scarce, international guidelines recommend that the SBP 
should be maintained between 140–180 mmHg during the endovascular procedure.64 
This approximately corresponds to a SBP drop of 10% from common baseline values. 
In Paper I, both the occurrence of and actual time spent with MAP more than 20% 
and 40% below baseline values were common findings, despite the fact that > 70% 
of all patients were treated with vasopressors. Whalin et al42 reported a > 20% fall in 
MAP in more than 50% of the patients receiving GA. Eighty percent of their patients 
received vasopressor therapy. Thus, GA for endovascular therapy in AIS is associated 
with pronounced aberrations of arterial blood pressure from baseline, despite vaso-
pressor therapy in the majority of the patients. 
Notably, despite the unsatisfactory blood pressure control in Paper I, 38% of the pa-
tients had a mRS score ≤ 2 at 3 months, which is a better result compared to GA pa-
tients in the other retrospective studies.67 Comparisons of blood pressure parameters in 
the retrospective studies and in Paper I and Paper II are shown in Table 7 and Table 8. 
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NA
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147
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61
68
104
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89
101
2012
2014
2014
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2010
2014
2014
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2015
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Baseline MAP 
mmHg
Blood pressure comparisons Baseline SBP  
mmHg
Lowest MAP 
mmHg
Lowest SBP 
mmHg
Table 7. Comparisons of blood pressure parameters (baseline values and lowest peri-pro-
cedural values) between the retrospective studies, Paper I and Paper II. MAP; mean arterial 
pressure, SBP; systolic blood pressure.
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Table 8. Comparisons of more specific data on peri-operative blood pressure measures 
presented in the retrospective studies with corresponding results from Paper I and Paper II. 
MAP; mean arterial pressure, SBP; systolic blood pressure.
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Author Year GA CS
44% of patients reached target 
SBP 140-180 mmHg
13% of patients experienced a 
MAP < 60 mmHg  
28% of patients experienced a 
20% fall in baseline MAP  
4% of patients reached target 
SBP 140-180 mmHg 
11% of patients experienced a 
MAP < 60 mmHg  
60% of patients experienced a 
20% fall in baseline MAP 
0% of patients reached target 
SBP 140 –180 mmHg
15% of patients experienced a 
MAP < 60 mmHg  
54% of patients experienced a 
20% fall in baseline MAP 
0% of patients reached target 
SBP 140 –180 mmHg
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Blood pressure comparisons
Due to the poor blood pressure control during EVT in our institution, detected in 
Paper I, we changed our institutional guidelines, with a more aggressive treatment of 
intra-operative hypotension. As a result, the MAP fraction was considerably higher 
in Paper II than in Paper I (Figure 25) and the occurrence of a MAP fall > 40% from 
baseline was markedly lower.
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MAP fall ≤ 40% from baseline 0 1 2 3 4 5 6
Figure 25. MAP fraction during EVT for patients in Paper I versus patients in Paper II. Mean values.
The more accurate treatment of hypotension resulted in only a minor difference 
between the blood pressures in the GA versus the CS group in Paper II. Thus, one 
explanation for equivalent neurological outcomes between the GA and CS groups in 
the AnStroke trial, despite the higher NIHSS at admission in the GA group, could 
be the fact that arterial blood pressure was now only marginally lower in this group. 
Notably though, also in the AnStroke trial there was a trend for worse outcome in the 
patient group experiencing a MAP fall of > 40% from the baseline value, comparable 
with the result from Paper I (Figure 26).
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Figure 26. Neurological outcome expressed as modified Ranking Scale (mRS) for patients in 
Paper II (AnStroke trial) with MAP fall > 40 % and ≤ 40 % from baseline respectively. 
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In summary, hypotension during EVT is common, both in GA and CS, and AIS 
patients are particularly sensitive to hypotension until revascularization is achieved. 
Hypotension is an independent predictor for poor neurological outcome and should 
be treated aggressively.
Ventilation 
Hypercapnia 
Hypercapnia (defined as PaCO2 > 6 kPa), has been postulated as a benefit for the CS 
patients in the retrospective studies, presuming that the patients hypoventilate and that 
the resulting hypercapnia facilitates cerebral blood flow by cerebral vasodilation.50 
This theory however, has at least two limitations. First, there are hardly no studies on 
ventilator parameters during EVT and it has not been shown that patients under CS for 
EVT do hypoventilate. On the contrary, Mundiyanapurath et al, showed that patients 
under CS were hyperventilating.108 Whether the CS patients hyper- or hypoventilate is 
of course largely dependent on the dose of sedative anesthetics administered. In Paper 
II, the CS group was normoventilated, probably due to a higher dose of remifentanil 
administered, compared to the study by Mundiyanapurath et al. 
The second limitation is that, even if CS does in fact cause hypoventilation and 
hypercapnia, the assumption that blood flow to penumbra tissue increases might be 
wrong. If the vessels in the penumbra tissue are already maximally dilated, due to the 
pressure-autoregulation mechanism, dilation only occurs in the surrounding vessels. 
This might cause a “steal phenomenon” with diminished, instead of increased, blood 
flow to the penumbra region. Notably, it has also been shown that vessels in ischemic 
tissues have reduced vasodilatory capacity in response to hypercapnia.109
Hypocapnia 
Well-known effects of hypocapnia (defined as PaCO2 < 4.5 kPa) are cerebral vasocon-
striction and a left-ward shift of the oxygen dissociation curve, possibly impairing the 
oxygen delivery to the penumbra.63 Existing data suggest that hypocapnia is associa-
ted with poor prognosis in stroke patients and it has been suggested that anesthesia 
staff routinely hyperventilate neurological patients during GA.110, 111 As mentioned, 
the vessels in ischemic tissues have reduced vasodilatory capacity in response to 
hypercapnia, but on the contrary, the ability to constrict in response to hypocapnia 
is preserved.63, 109, 112
Indeed, Takahashi et. al. showed that hypocapnia was associated with poor neuro-
logical outcome in patients undergoing EVT in GA for AIS. Mean ETCO2 was 4.7 
kPa for patients with favorable outcome and 4.3 kPa for patients with unfavorable 
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outcome, with an OR for unfavorable outcome of 1.3 per 0.13 kPa decrease in 
ETCO2.113 In Paper I (only GA patients), ETCO2 values were in the lower range 
as compared to values presented in the study by Takahashi. However, values were 
similar in both outcome groups (median values 4.4 kPa and 4.3 kPa in the favorable 
vs unfavorable outcome group respectively) and we did not find an association bet-
ween ETCO2 and neurological outcome in a logistic regression analysis (Table 2). 
Importantly, the GA group in Paper II was not hyperventilated (median PaCO2 5.4 
kPa in the GA group, which can be compared to 5.2 kPa in the CS group). In Paper 
II, PaCO2 was not associated with neurological outcome in a univariate logistic 
regression analysis (data not published). 
In summary, the influence of hypercapnia and hypocapnia on penumbra blood flow 
in AIS is not extensively studied. International guidelines recommend normocapnia 
(PaCO2 4.7-6.0 kPa) in the GA group and to avoid hypercapnia in the CS group.64 
Worth noticing is that ETCO2 does not always accurately represent the true PaCO2, 
due to situations with ventilation/perfusion mismatch.114 Thus, in future studies, 
arterial blood gases should be drawn repeatedly for accurate measurements of 
PaCO2, together with close blood pressure monitoring. 
Oxygenation 
Hypoxemia 
Hypoxia is a common feature in patients admitted for stroke although there is no 
consensus on the hypoxia definition (hemoglobin oxygen saturation ranging from < 
90% to < 96% and PaO2 < 8 kPa in different studies).115, 116 In one study, 63% of AIS 
patients experienced hemoglobin oxygen saturation < 96 % for more than 5 minutes 
during the initial 48h from admission.116 In a healthy subject experiencing hypoxia, 
brain vessels vasodilate to compensate for a decrease in blood oxygen content.117 
However, in the penumbra region, vessels have reduced capacity to vasodilate in 
response to eventual hypoxia.118  
The occurrence of hypoxia is associated with worse neurological outcome after 
stroke; Rocco et al reported an OR of 15 for poor outcome in hypoxic patients com-
pared to non-hypoxemic patients (hypoxic defined as occurrence of pulse oximetry 
values < 92% during hospitalization).119 However, it remains unclear whether hypoxe- 
mia is the cause, or just a sign, of poor prognosis. Also, limited and divergent data 
exist on the benefit of supplemental oxygen. In the published randomized studies on 
supplemental oxygen, the oxygen was administered within 12–48 hours after stroke 
onset, often without data on hemoglobin oxygenation saturation or PaO2 and without 
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data on reperfusion strategies or reperfusion results.120-124 Thus, the interpretation of 
the results and their relevance in an acute setting during EVT can be questioned. 
Hyperoxia 
In the literature, there have been concerns about negative effects of oxygen supple-
mentation, as oxygen encourage the formation of toxic free radicals, that could harm 
the vulnerable penumbra. However, studies showing toxic free radical production in 
AIS, used late treatment onset, animal models, long-term oxygen therapy and often 
hyperbaric treatments.125 Another concern has been that oxygen supplement could 
result in hyperoxia (PaO2 > 13 kPa), known to induce cerebral vasoconstriction, that 
could theoretically compromise blood flow to the penumbra tissue. However, in the 
ischemic brain, hyperoxia is described to paradoxically increase cerebral perfusion 
by vasodilation.123
In conclusion; whether or not oxygen supplement is beneficial when administered 
before revascularization, in order to extend the reperfusion window, is not studied. 
Nonetheless, in international guidelines, supplemental oxygen in EVT is only recom-
mended if hemoglobin oxygen saturation is < 92%.64
In Paper II, all patients received supplemental oxygen, according to our institutional 
guidelines, and hemoglobin oxygen saturation as well as PaO2 were higher than the in-
ternational recommendations, and also significantly higher in the GA group compared 
to the CS group. Hemoglobin oxygen saturation and PaO2 were not associated with 
neurological outcome in a univariate logistic regression analysis (data not published).
Anemia 
In addition to hemoglobin oxygen saturation, the hemoglobin concentration is of im-
portance for the blood oxygen content. Many of the AIS patients are anemic (defined 
as hemoglobin concentration < 120 g/L for women, < 130 g/L for men) at admission; 
25% in a study by Barlas et al and the common routine to administer intravenous 
crystalloid solutions might result in a dilution anemia.126 
Hemoglobin concentrations in AIS are associated with infarction growth127 and mor-
tality126, 128 and describes a U-formed curve in relation to the neurological outcome, 
outcome being worse with very low and very high hemoglobin concentrations.129 
Dilution with crystalloid solutions to lower the hemoglobin concentration and theo-
retically improve the blood rheology in AIS, has not been demonstrated beneficial.130 
Furthermore, erythrocyte transfusions to rise the concentration, did not improve 
neurological outcome in NICU treated AIS patients in a study by Kellert et al.131 
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The impact of acute erythrocyte transfusions on neurological outcome in the anemic 
AIS patient, has not been studied and no target hemoglobin concentration is available 
in international guidelines.64 In Paper II, 33% of the patients were anemic (definition 
above) at admission. Two patients received erythrocyte transfusions during the EVT. 
Hemoglobin concentration was not associated with neurological outcome in a univariate 
logistic regression analysis in our study (data not published). 
Blood glucose 
Forty percent of the AIS patients are hyperglycemic (defined as blood glucose > 7.8 
mmol/L) at admission according to Alvarez-Sabin et al.132 Blood glucose was seldom 
reported in the cited retrospective studies, although hyperglycemia is a well-known 
negative prognostic factor for neurological outcome in AIS and associated with reduced 
benefit from recanalization with IVT.132-135 
Blood glucose during EVT was studied by Kim et al, showing that patients with hy-
perglycemia were less likely to achieved an excellent outcome (mRS ≤ 1) at 3 months 
compared to patients without hyperglycemia.134 Li et al and Davis et al also presented 
data on hyperglycemia as an independent predictor of mortality and poor neurological 
outcome after EVT.43, 48 
 
Randomized studies on insulin therapy in AIS in general have failed to show any out-
come benefit when therapy was initiated 6–24 hours after stroke onset.136 Instead, there 
was an increased risk of hypoglycemic episodes in the treatment group. Hypoglycemia is 
a well-known devastating condition, with the potential to cause secondary brain injury. 
For hyperglycemia, the question remains whether this, per se, worsens the prognosis 
(hyperglycemia leads to cerebral acidosis and could potentially exaggerate the neuronal 
injury) or if hyperglycemia merely is a physiological stress response indicating a more 
severe stroke. 
In international guidelines, target blood glucose is set to 7.8–10 mmol/L.64 In Paper I 
and Paper II, the patients had mean blood glucose values under the hyperglycemia-limit 
and blood glucose was not associated with neurological outcome in univariate logistic 
regression analyzes (Table 2) (Data for Paper II not published).
Anesthetic drugs 
In several of the retrospective studies, it is suggested that higher doses of anesthetic 
drugs during GA attenuate the cerebral autoregulation, contributing to the worse out-
come in the GA group.40, 45, 49, 52-55 On the other hand, some authors mention the possibility 
of a dose-dependent neuroprotective effect by the anesthetics.42, 45, 52 
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Anesthetics do attenuate the cerebral autoregulation, although to varying extent; 
inhalation anesthetics more pronounced than propofol while isoflurane has a more 
pronounced effect than sevoflurane.137-139 Dexmedetomidine also has a negative impact 
on cerebral autoregulation,140 while opioids, on the other hand, preserve autoregula-
tion.137 Whether the influence from anesthetics on autoregulation is important or not 
during EVT is unknown. As mentioned earlier, autoregulation in ischemic tissues is 
already diminished or lost. 
Regarding the neuroprotective effects, inhalation anesthetics reduce cerebral meta-
bolic rate (CMR) but retain cerebral blood flow (CBF) in contrast to propofol, which 
diminishes CMR but also the CBF.137 Opioids and dexmedetomidine, exhibit a less 
pronounced decrease in both CMR and CBF compared to inhalation anesthetics and 
propofol.137 Indeed, Sivansankar et al reported better neurological outcome after EVT 
in GA if patients received inhalation anesthesia (desflurane or sevoflurane) when 
compared to intravenous anesthesia (propofol).141  
All patients in Paper I and the GA patients in Paper II, were subjected to inhalation 
anesthesia (sevoflurane plus remifentanil). In Paper II the CS group received remifen-
tanil. The GA group in Paper II had, due to chance, higher NIHSS, higher incidence 
of proximal occlusions and left-sided lesions, yet equivalent neurological outcome 
to the CS group. 
Thus, one could speculate on GA showing a neuroprotective effect in Paper II (An-
Stroke trial). A randomized trial on intravenous versus inhalation anesthesia would 
be of interest in the future.
Anesthetic complications
Another matter of debate in the retrospective studies, has been the rate of complica-
tions with GA and CS respectively. One reason for worse outcome in the GA group 
was considered to be more frequent aspiration pneumonia in this group. Undoubtedly, 
there was a higher incidence of pneumonia in the GA group in the AnStroke trial, as 
in several previous studies.41, 46, 47, 50 Most likely this is due to the invasive ventilation, 
since the risk of aspiration, per se, applies to both GA and CS.142 However, all patients 
with pneumonia in Paper II were treated with antibiotics and postoperative pneumo-
nia was not associated with neurological outcome in a univariate logistic regression 
analysis (data not published).
Regarding interventional complications, patient agitation and patient movements 
during CS are considered to possibly hamper catheterization and degrade angiography 
quality, which can lead to an increased complication frequency.67 This has not been 
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proven in previous studies and in the AnStroke trial, even though the angiographic 
quality was worse and substantial patient movements were more frequent in the CS 
group; this was not associated with more complications, e.g. vessel perforation. 
Time is brain 
It has been claimed that one major disadvantage of GA and intubation for EVT is the 
potential risk of delaying the procedure start time. This means a prolonged CT to groin 
puncture time, which could affect the treatment outcome.44, 53, 55, 68 The CT to groin 
puncture time in the AnStroke trial, was almost identical for the two groups (≈ 90 
minutes) and there was no difference in the CT to recanalization time (≈ 160 minutes). 
The specific time intervals that could be affected by anesthesia technique are rarely 
presented in previous studies, namely time “from arrival to neurointervention suite to 
groin puncture” (possibly longer for GA due to induction of anesthesia and intubation) 
and “from groin puncture to recanalization” (possibly shorter for GA because of better 
working conditions for the neurointerventionist). In the AnStroke trial, there was a 
trend towards longer “from arrival to neurointerventional suite to groinpuncture” time 
interval in the GA group, which was compensated by a shorter “from groin puncture 
to recanalization” time interval.
On-hour versus off-hour
In Paper III, we found a substantial delay in the time interval from admission CT 
to recanalization for AIS patients admitted for EVT during off-hours (median 20 
minutes). Time from groin puncture to recanalization was similar during on- and 
off-hours, suggesting that no delay in treatment was caused by the responsible neu-
rointerventionists. The longer CT to recanalization time during off-hours could not 
immediately be explained by differences in patient characteristics, differential use 
of general anesthesia, the extent of IVT or proportion of admissions from regional 
hospitals, as all these factors were similarly distributed between the on- and off-hour 
group. Most likely, the time delay during off-hours was due to a reduced hospital 
staffing, experience and competence of the involved professional teams during nights 
and weekends. Importantly though, the off-hour admission per se, was not an inde-
pendent predictor for poor outcome. 
Delay in the CT to recanalization time seen off-hour is previously described, and the 
20 minutes delay in the present study is well in agreement with the results presented 
in some earlier studies.17, 18 Several authors suggest that CT to recanalization time is 
a relevant in-hospital performance metrics, since it can be modified by the hospital 
personnel.19, 143 Furthermore, the time interval is shown to be an important indepen-
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dent predictor of the neurological outcome after EVT. In the ESCAPE trial, every 30 
minutes increase in CT to recanalization time, reduced the probability of achieving 
good neurological outcome (mRS ≤ 2) by 8.3%.19 These figures are in line with the 
results from Paper III, showing an OR of 0.991 for good neurological outcome for 
every minute delay in the time interval CT to recanalization.
Although there was a substantial time delay in off-hour EVT treatment for AIS in 
the present study, the observed delay did not translate into a statistically significant 
difference in the proportions of good neurological outcome between the on-hour 
and off-hour groups (43% and 37% respectively, p=0.47). This could be explained 
by the fact that the groups were unbalanced with respect to NIHSS and incidence of 
ischemic heart disease. The NIHSS was significantly higher in the group of patients 
admitted on-hour, which could level out the beneficial effects of shorter lead times 
on neurological outcome. Furthermore, the incidence of ischemic heart disease was 
more than twice as high in the on-hour group, indicating that this group had a more 
pronounced arteriosclerotic disease. Similarly, neither Almekhlafi et al nor Mpotsaris 
et al, both including about 100 patients in their studies, with similar off-hour delay 
(approximately 20 minutes), could detect differences in neurological outcome.17, 18 Also 
in those studies, group imbalances were demonstrated. In the study by Mpotsaris et 
al, for example, patients admitted on-hour were significantly older. 
After several randomized trials reporting efficacy of EVT over standard medical care 
with IVT in AIS, the number of patients eligible for EVT is estimated to increase 
three- to five-fold in the coming years.6 This will put a harder strain on the stroke 
organization during off-hours (as well as during on-hours) and the results in Paper III 
mandate further analysis and measures to correct the imbalance between time inter-
vals for on- versus off-hour admittance. Increased resources will have to be allocated 
to EVT in AIS, investments that soon will repay themselves, as short- and long-term 
costs diminish for every patient achieving an independent neurological outcome.144
 
Anesthesia technique – prospective studies
To our knowledge, the AnStroke trial (Paper II) is the second prospective randomized 
trial comparing GA with CS for EVT in AIS. The recently published SIESTA trial68 
showed that CS did not result in better early neurological recovery (primary outcome), 
as assessed by NIHSS 24h, a finding that was confirmed in our study. On the other 
hand, in the SIESTA trial, the proportion of patients having good neurological out-
come (mRS ≤ 2) at three months (secondary outcome) was significantly higher in the 
GA group (37%) compared to the CS group (18%). 
52 Pia Löwhagen Hendén
In the AnStroke trial, including patients with equally high admission NIHSS as the 
SIESTA trial, the proportion of patients having a mRS ≤ 2 at three months was app- 
roximately 40% in both groups. The low incidence of good neurological outcome 
in the CS group in the SIESTA trial could be explained by the fact that the staff, 
according to the authors, was less experienced with the CS technique at the time of 
their study start. 
The SIESTA trial results emphasize the importance of staff familiar with both an-
esthesia techniques. Most importantly, neither the SIESTA nor the AnStroke trial 
could demonstrate that GA results in worse neurological outcome compared to CS, 
as suggested by previous retrospective studies.
Methodological considerations Paper I–III
Paper I 
• The major limitation of the study is its retrospective design.  
• Although intra-arterial blood pressure was continuously monitored during the EVT 
procedure, the accuracy of the anesthesia chart recorded blood pressures was limi-
ted to ± 5 mmHg.
• The MAP limit of more than 20% fall from baseline, was chosen in accordance 
with international guidelines which propose a maximum drop of BP of 10-20% 
from baseline during EVT. As all patients had a 10% MAP fall from baseline, the 
20% limit was selected. A 40% fall in MAP from baseline represents, in average, 
the BP at which the cerebral autoregulation curve reaches its steep part and the 
cerebral blood flow becomes linearly dependent on the cerebral perfusion pressure.
Paper II
• The power calculation in Paper II was based on published retrospective studies on 
anesthesia for EVT before 2012, showing large differences in neurological outcome 
for GA versus CS groups. The incidence of good outcome varied as much as 20-40 
percent units between the GA and CS groups. The AnStroke trial was powered to 
detect a difference of that magnitude with an inclusion of 80 patients, a reasonable 
number in a single-center setting. We included 90 patients, assuming a 10% loss 
to follow-up. However, the size of the study was limited and a small difference in 
outcome would have been difficult to interpret, had it occurred.
• The NIHSS limits of ≥ 10 was the institutional limit used for EVT eligibility at 
the time of study design (≥ 14 if there was a dominant hemisphere occlusion) since 
this magnitude of NIHSS is associated with large vessel occlusions. Since recently 
discovered evidence was published, supporting the efficacy of EVT also for lower 
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NIHSS, all patients with NIHSS ≥ 6 are now eligible for EVT. 
• We did not use a detailed study protocol for the anesthesia procedure per se, which 
would have been ideal, but at the time for the trial design, that approach was not 
considered feasible. The study patients were managed according to our institutio- 
nal guidelines for anesthesia during EVT. All patients in the GA group received 
maintenance anesthesia with sevoflurane and remifentanil and all patients in the 
CS group received remifentanil. 
• The study was blinded in all relevant aspects: The neuroradiologists reviewing the 
CT and MRI examinations were blinded to anesthesia type, recanalization grade 
and neurologic outcome. The angiographic data were reviewed by neuroradiologists 
blinded to the CT and MRI reviews, as well as to neurologic outcome (but not to 
the anesthesia type, as a tracheal tube can be seen on the angiographic images). 
• The primary endpoint was evaluated by a vascular neurologist, blinded to treatment 
allocation and recanalization grade, assessing mRS by direct examination of 81 
patients (90%). In most studies, as the recently published SIESTA trial, only tele-
phone interviews are performed by a modified Rankin Scale–certified investigator.68 
• No patient was lost to follow-up.
• As the AnStroke trial was a single center study, the results cannot automatically 
be applied to other centers with different neuroanesthesiological and neurointer-
ventional approaches.
Paper III
The cohort in Paper III was a merger of the retrospective cohort in Paper I and the 
prospective cohort in Paper II and the patients were thus not consecutive. However, for 
the purpose of the study, namely to assess the differences in time intervals between 
on- and off hour stroke admittances, the new cohort was adequate. The number of 
included patients was twice the number in earlier studies and collected data included 
extensive information on prognostic factors for stroke outcome.
Ethical considerations Paper I–III
The studies were approved by the Gothenburg Regional Ethical Review Board, docu- 
ments no 455-12 and no 013-13. 
Paper I was a retrospective observational study. 
The two anesthesia techniques used in Paper II (a prospective study) were both stan-
dard procedures in our institution before the start of the trial. We did not consi- 
der the randomization as an ethical dilemma, as patients with medical indication or 
contraindication, for any of the two techniques, were excluded. Nevertheless, oral 
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informed consent was collected, as required by the Regional Ethical Review Board 
before randomization, from the patient or next of kin (if the patient was aphasic). 
This was done without prolonging the treatment initiation, and a written consent was 
mandatory after the treatment was completed, either from the patient if possible, or 
otherwise from next of kin. 
Due to the urgent circumstances, oral consent could not be awaited. For this reason, 
14% of the otherwise eligible patients could not be included. In those cases, the patient 
was subjected to one of the two anesthesia techniques chosen by the anesthesiologist 
in charge.
Autonomic nervous system and traumatic brain injury 
The main finding in Paper IV was that ANS dysfunction, during the first week in 
NICU, was associated with poor late neurological outcome. It was the first study to 
report longitudinal measurements of both HRV and BRS in a homogenous group 
of patients with traumatic brain injury, requiring mechanical ventilation, sedation, 
analgesia and cardiovascular support. In some previous studies, patients requiring 
sedation were excluded 80, 81 or the patients were subjected to early discontinuation of 
sedatives and analgesics.83 In other studies, data on the use of sedatives, analgesics, 
vasoactive drugs and mechanical ventilation were not presented.81, 82, 145 The results 
from our study however, showed that monitoring signals from ANS was feasible 
during ongoing full scale intensive care.
It is well known that thiopental, opioids, benzodiazepines and propofol reduce HRV86, 
87, 89, 91, 94, 95 and BRS.84, 85, 90, 92, 93 There were however no evident differences between 
the two outcome groups in Paper IV with respect to the doses used, although the 
limited number of patients precluded statistical calculations on this matter. Further 
on, mechanical ventilation may induce a decrease in LF and an increase in HF.146 
Importantly mechanical ventilatory modes were maintained constant throughout 
the study period, with no patient regaining spontaneous breathing during that time. 
In previous studies, several attempts have been made to predict outcome from HRV 
analysis, such as brain death147, ICU mortality 80, 83, 30-day mortality and GOSE < 5 
at three months.81 Paper IV was the first study on the power of autonomic variables 
to predict long-term neurological outcome. The power of BRS and HRV variables to 
predict GOSE < 5 at one-year follow-up were acceptable.
The association of autonomic dysfunction with worse neurological outcome in TBI 
is thus reported in several studies.80-83 The mechanisms of the poor outcome are 
suggested to be cardiovascular complications, insulin resistance, attenuated cerebral 
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autoregulation, brain edema and immunological effects mediated via the cholinergic 
anti-inflammatory pathway, causing immune suppression and infection susceptibili-
ty.148, 149 In Paper IV we lack data on cerebral autoregulation, infectious complications 
and insulin requirements and thus cannot have an opinion on the contribution of such 
factors on outcome.
In 2016, Sykora et al presented a large retrospective study on 262 TBI patients, all 
treated in the ICU with sedation and mechanical ventilation. The showed that BRS 
and HF power were independent predictors of mortality and unfavorable neurological 
outcome.148 Thus, their findings are in line with our results, yet the strength of our 
study is the longitudinal capture of data, making a temporal resolution possible. In 
the study by Sykora et al, mean values for the whole length of stay were used. 
In summary, the findings in Paper IV, suggest that HRV, as well as BRS can be used 
to predict outcome in TBI patients with advanced neuro intensive care treatment. 
Although signals from the autonomic nervous system are attenuated during ICU 
treatment, they are still detectable and offer information on prognosis. With new 
automated devises, the HRV and BRS values can be followed on line as a part of a 
multi-modal monitoring of TBI patients. With a temporal resolution, a patient at risk 
of worse outcome can be identified, and diagnostic- and therapeutic actions inten-
sified. Whether the autonomic impairment per se is a possible therapeutic target, as 
suggested by Sykora et al148, remains to be elucidated. 
Methodological considerations Paper IV
• The weaknesses of the study lie within the retrospective design, hampering comp-
lete data acquisition, and the limited number of patients. 
• The observed ICU mortality (one out of 19 patients) precluded any mortality out-
come analyzes (as reported in previous studies) with HRV and BRS as predictors. 
Therefore, only the 1-year GOSE score was used as the outcome variable. 
• HRV measured in frequency domain is sensitive to arrhythmias, commonly seen in 
brain injured patients. In our study all data were manually checked for ectopic beats. 
• Acquisition of data was standardized to a 60-minute period free of nursing interven-
tions, in the early morning (5–7 a.m.). However, we cannot exclude the possibility 
that some measurements were influenced by factors in the ICU care.
Ethical considerations Paper IV
This strictly observational study was approved by the Gothenburg Regional Ethical 
Review Board, document no 292-08. 
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Conclusions
Concerning patients undergoing endovascular treatment for acute ischemic stroke, 
we found that profound intra-procedural hypotension during general anesthesia is an 
independent predictor of poor neurological outcome (mRS ≤ 2) at 3 months.  
Randomizing patients to general anesthesia or conscious sedation did not result in 
any difference in mRS at 3 months; neither in early neurological recovery, in cerebral 
infarction volume or in angiographic outcome between the two groups.
Off-hour admissions result in a substantial delay in the time interval from CT to 
recanalization. This time interval is an independent predictor of poor neurological 
outcome. 
Regarding patients with acute traumatic brain injury (TBI), autonomic nervous system 
dysfunction, as assessed by heart rate variability (HRV) and baroreflex sensitivity 
(BRS), during the first week of neuro intensive care, is associated with poor late 
neurological outcome. 
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Future perspectives
For years, the main focus in anesthesia during EVT has been on anesthesia form more 
than on anesthesia performance. Most aspects of anesthesia management during EVT 
are not yet studied, except for the blood pressure control. 
Factors as ventilation, oxygenation and glucose control might be important for penum-
bra salvage and can be controlled and corrected by anesthesia- and intensive care staff 
in the acute setting, before, during and right after the recanalization. Both optimal 
oxygen delivery and glucose control may be beneficial as bridging therapies during 
the transient ischemic period before revascularization. In addition, some anesthetics 
might be preferable in providing neuroprotection. Whether these theories are relevant 
or not will have to be explored in future studies.
Monitoring of heart rate variability and baroreceptor reflex sensitivity might be ad-
junct tools in multi-modal monitoring of traumatic brain injury in the future since 
on-line devices now are available. 
Finally, as a bridge between paper I–III and Paper IV: In acute ischemic stroke (AIS), 
ANS dysfunction, as assessed by HRV or BRS, is repeatedly shown to be associated 
with stroke severity, early and late complications, dependency and mortality.150 Early 
diagnosis of ANS dysfunction in stroke may have prognostic and possibly also thera- 
peutic values in acute stroke, as stated in the review by Yperzeele et al.150
Furthermore, several aspects of ANS dysfunction in AIS are yet to be investigated; 
for example, the effect on HRV and BRS of recanalization. Are on-line measurements 
of HRV and/or BRS a method to non-invasively monitor the process of recanalization 
in IVT and EVT? This question can be addressed in future studies.
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